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ABSTRACT 
The discovery of Krüppel-Like Factor (KLF) proteins has contributed more than one 
could have imagined regarding the mechanisms that underscore complex physiological 
and pathological phenotypes. From the start, our laboratory hypothesized that elucidating 
the intricate network of interactions between KLF transcription factors and epigenetic 
machinery would provide significant insight into the mechanisms of human diseases. 
Drawing from nearly two decades of data and utilizing a novel system biology approach, 
we propose the novel hypothesis that KLF proteins function as master transcription 
factors to deliver epigenetic information to an orchestra of gene promoters, influencing 
chromatin dynamics and global patterns of gene expression. Multidimensional 
comparison and visualization of robust experimental datasets using a paradigm 
transcription factor, KLF11, illustrate the complicated, yet delightful nature of the 
relationship between KLF proteins and their chromatin cofactors, providing exciting 
revelations into the causes, prognosis, and therapeutic management of complex diseases. 
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CHAPTER 1:  
Introduction 
  2 
Uncovering the environmental and genetics factors underlying the etiology of complex, 
non-Mendelian human diseases remains an elusive goal of biomedical research. Despite 
the herculean efforts of genome wide association studies (GWASs) and high throughput 
genomic technologies, alterations in DNA sequence alone have failed to provide 
complete causality for the highly variable presentation and therapeutic responsiveness of 
common complex pathologies. Sequencing and re-sequencing retain their promise of 
unlocking further critical associations between genetic variation and disease. However, 
non-genetic determinants—particularly epigenetic factors—have garnered increasing 
attention as probable culprits in the origination, susceptibility, or progression of many 
complex diseases. 
 
Epigenetics refers to the regulation of gene expression mediated by heritable, yet 
theoretically reversible, changes in chromatin structure that influence the accessibility of 
transcription factors to the DNA template. Chromatin is comprised of DNA and proteins 
that permit the compaction of duplex DNA into the fixed volume of the nucleus. The first 
layer of chromatin organization occurs at the base unit, the nucleosome, where 
approximately 146 base pairs of DNA are wrapped around an octamer of basic histone 
proteins (H2A, H2B, H3, and H4) and stabilized by a single molecule of H1. Each 
primary array of nucleosomes, termed the “beads on a string” conformation, is further 
folded and compacted into tight fibers of arrays, eventually condensing into individual 
chromosomes. Euchromatin denotes the open, transcriptionally accessible state of the 
chromatin, while heterochromatin refers to the closed, transcriptionally inaccessible state. 
Within the nucleoplasm, chromatin is further subdivided into membrane-free 
compartments with heterochromatin distributed along the nuclear periphery, proximal to 
the nuclear lamina, and euchromatin located more centrally. Other, smaller compartments 
exist that are organized toward a common function, e.g. rRNA transcription in the 
nucleolus. Reconfiguration of chromatin state may occur through a number of 
mechanisms, including (i) methylation of DNA at cytosine/guanine (CpG) dinucleotides 
via DNA methyltransferases, (ii) the action of ATP-dependent chromatin remodeling 
complexes to alter or remove nucleosomes, (iii) posttranslational modifications 
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(acetylation, methylation, phosphorylation, etc.) of residues on the amino terminal tails of 
histone proteins by histone modifying enzymes (histone code hypothesis), and (iv) the 
incorporation of variant histones into nucleosomes. All modifications to chromatin are 
potentially reversible, a fact that holds clear therapeutic potential to permit primary 
treatment options for diseases currently only treated at the level of symptom management 
(1).  
 
Epigenetic variation: “New” culprit in complex disease? 
Epigenetics mechanisms are highly conserved among all eukaryotic species and knockout 
of epigenetic regulators is frequently embryonic lethal, demonstrating that both the 
fidelity of DNA sequence and its epigenetic status are critically important to the proper 
function of an organism’s genetic program. The number of currently identified epigenetic 
molecules, modifications, and mechanisms is enormous, illustrating the dynamic 
flexibility inherent in the system to respond rapidly to internal programs or environmental 
stresses. Organism development, where many epigenetic molecules and processes were 
first characterized, provides dramatic examples of the profound consequences of 
epigenetic modifications on gene expression networks. The monarch butterfly possesses 
the same genetic information throughout its metamorphosis yet epigenetic regulation of 
gene expression manifests in two drastically different phenotypes, caterpillar and 
butterfly. Furthermore, while the lifespan of a monarch is typically only 4-5 weeks, a 
unique subset of monarchs is born each year, the “Methuselah generation,” that survive 
for up to 7-8 months and undergo a roundtrip migration from Canada/United States to 
Mexico. Differentially expressed microRNAs were uncovered between the summer and 
migratory populations to partially explain this phenomena (2). While genetic in origin, 
regulation in the expression and timing of these microRNAs is mostly likely epigenetic. 
Thus, a single genome may possess effectively infinite epigenetic states and 
corresponding patterns of gene expression. 
 
Epigenetic variations arise as either a cause or consequence of disease. The need to 
determine pre-existing versus acquired epigenetic status as well as the advent of high 
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throughput epigenomic screens (e.g. whole genome DNA methylation assays) has fueled 
the development of epigenome-wide association studies (EWASs) (3). Pre-existing 
epigenetic variations may be transgenerational, inherited from patterns established in the 
parental gametes and disseminated to all or selective tissues in the subsequent generations 
(4). Other variations may arise stochastically (5). The penetrance of the variation is then 
dictated by the chronological timing of the imprinting event with early developmental 
events possessing a stronger likelihood of dispersed effects. Finally, variation may be 
directly linked to environmental exposure (e.g. smoking, alcohol) or lifestyle choices 
(e.g. diet) (6). The lifestyle choices of an ancestral population may result in the 
generation of heritable epialleles disseminated to their offspring. Inherited epigenetic 
variation, or “soft inheritance,” is a prime candidate for explaining the observed 
phenotypic variability of complex diseases insufficiently accounted for by “hard 
inheritance,” i.e. genetic and environmental variation (7). 
 
The overall accessibility of the DNA template to transcriptional machinery is highly 
dependent on the chromatin landscape. Until recently, the relationship between chromatin 
and transcription factors appeared largely passive, with chromatin confirmation, histone 
modifications, and DNA methylation governing the affinity between trans-acting factors 
and their binding sites on gene promoters. However, the evidence that overexpression of 
four transcription factors—Oct4, Sox2, m-Myc, and KLF4—is sufficient to reprogram 
fully differentiated fibroblasts into pluripotent ES-like cells suggests an active role for 
transcription factors in the epigenetic regulation of chromatin state (8). KLF proteins, in 
particular, have demonstrated a multitude of feed-forward effects on epigenetic 
regulation of gene expression. Here we propose KLF proteins as a model for 
understanding the critical role of sequence-specific factors in epigenetic regulation of a 
number of complex diseases, including diabetes, obesity, and cancer. 
 
Discovery of Sp1 and Sp1-like sequence-specific DNA-binding transcription factors 
Prior to 1980, the manner in which genes responded to specific stimuli to execute 
programs of protein expression was unclear. Between 1983-1987, Robert Tijan and 
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colleagues at the University of California purified and cloned the first mammalian 
transcription factor, named Specificity Protein 1 (Sp1), and demonstrated that Sp1 could 
activate the simian virus 40 (SV40) promoter by binding GC-rich elements via three 
contiguous C2H2 zinc finger motifs in its C-terminus (9,10). Subsequently, ~2% of the 
human genome has been found encode C2H2 zinc finger proteins, making it the second 
largest subset of transcription factors after the odorant receptor family (11). Early 
homology analysis pointed to the D. melanogaster “gap” segmentation gene Krüppel as a 
potential ancestral gene given the high degree of conservation of both the zinc finger 
region as well as a seven-amino acid spacer region between the fingers, the H/C link (12).  
 
The discovery of Sp1 and momentum of the cloning era fueled a decades-long hunt for 
structurally and functionally related mammalian transcription factors. In 1992, Fujii-
Kuriyama cloned two regulatory proteins bound to a GC-rich basic transcription element 
(BTE) in the rat—Sp1 and basic transcription element B1 (BTEB1/KLF9), a novel C2H2 
zinc finger protein with high similarity to Sp1. Interestingly, the two proteins displayed 
antagonistic effects on the CYP1A1 promoter (13). Identification of Sp2-4 followed 
(14,15) as well as Bieker reporting the cloning and characterization of human erythroid 
Krüppel-like factor (EKLF/KLF1), a factor capable of activating the -globin promoter 
through an Sp1-like target site (16). During the same period, our laboratory cloned and 
contributed two transforming growth factor- (TGF-)-inducible Sp1-like proteins, 
TIEG1 (KLF10) and TEIG2 (KLF11) (17,18). The “Krüppel-like factor (KLF)” 
designation ultimately triumphed in the nomenclature. In total, 17 different human 
proteins with similarity to Sp1/Krüppel within their zinc finger region have been 
identified that bind to GC-rich regions to regulate gene expression, forming the KLF 
family of proteins (19). Unlike the ubiquitously expressed Sp1, tissue expression patterns 
of individual KLFs vary widely and often hold organ-specific functions in development 
and function. Several excellent reviews have been published that detail the complete 
history and biochemical characterization of individual factors (19-21). 
 
Characteristic structural features of KLF family proteins 
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Site-sequence transcription factors must possess three defining characteristics: (i) a DNA-
binding domain, (ii) a nuclear localization signal (NLS), and (iii) transcriptional 
regulatory domain. The C-terminal DNA-binding domain houses three C2H2 zinc fingers 
of invariant length between KLF members (Figure 1A). The first two zinc fingers are 
precisely 23 amino acids in length with the third zinc finger spanning 21 amino acids 
(22,23). Separating each zinc finger is a highly conserved seven amino acid spacer, the 
H/C link (TGE(R/K)(P/k/r)(F/y)X) (12,24). The overall physical structure of the factor is 
divided into an N-terminus comprised of two -pleated sheets and a -helical C-terminus 
with each zinc finger chealating a single zinc ion. Each individual zinc finger makes 
contact with a trinucleotide repeat within the major groove of DNA (25,26). Although 
KLF members typically recognize GC-rich sequences containing either a CGCCC or 
CACCC core sequence, recognition sites have been observed to vary from those that 
would be predicted from the amino acid composition of a particular zinc finger protein 
(14,15,27-29). Variation may attributed to co-operative binding between zinc fingers 
altering the overall selectivity of the C-terminus, a “wobble” effect akin to that observed 
in protein translation, or altered composition of the H/C link.   
 
Sequence identity at the carboxyl terminus among KLF family members is greater than 
>65% (Figure 1B), suggesting the regulation of similar types of gene promoters and the 
potential for synergistic or antagonistic regulation by family members, with competition 
between factors functioning as “on” or “off” switches (19). Despite the high degree of 
sequence identity in their DNA-binding ability, the functional activities of KLF members 
differ widely. For instance, while Sp1 is one of the most potent activators of 
transcription, KLF11 is an equally powerful transcriptional repressor (17). Furthermore, 
several KLF family members have been observed to perform duel functions as activators 
in certain cellular contexts and repressors in others. The diversification displayed by 
family members is embedded in the high degree of variability within the N-terminal 
domain of each protein. The location of the NLS is one criterion to delineate family 
members, with one group possessing placement of the NLS within the zinc finger and the 
other directly upstream of this region (30,31). Far more diverse, however, are the 
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transcriptional regulatory domains of each family member that contain specific activation 
and repression elements that interact with distinct co-activators and co-repressors, thus 
permitting each factor to mediate the chromatin dynamics and transcription of individual 
gene promoters in a highly specific fashion (32-34). Although the highly conserved 
DNA-binding domain denotes their familial origins, the ultimate functional identity of 
each KLF protein rests in its N-terminal character.  
 
cabut: evolutionarily conserved root for the KLF mediation of complex phenotypes 
KLF proteins are highly conserved among species, from C. elegans to human (35). The 
recent availability of genome sequence from many organisms has permitted the 
unprecedented cataloguing of KLF homologs/orthologs, permitting advanced 
understanding in the evolution of these factors (Figure 1C). Unlike other important 
transcription factors, such as the Kruppel-associated (KRAB) box containing C2H2 zinc 
finger proteins, which underwent significant cluster expansion, the genes encoding KLF 
proteins are dispersed through the genome with the exception of KLF1 and KLF2, which 
share the same locus (11,21).  
 
In 2005, well after the identification of the human KLFs, Paricio reported the discovery 
of cabut, a novel gene involved in Drosophila embryogenesis, which encodes a 
transcription factor possessing a C2H2 zinc finger motif (36).  cbt mutants suffer lethal 
defects in dorsal closure with cbt expression occurring downstream of the JNK signaling 
cascade to positively regulate expression of dpp and alter cytoskeletal dynamics along the 
leading edge (36). Structural analysis of cbt revealed that the closest human homologs are 
KLF10 and KLF11 (37,38).  KLF10/11 possesses three repressive domains in their N-
terminal region responsible for mediating interactions between co-activators and co-
repressors. cbt displays complete conservation of the serine-and proline-rich R3 domain 
of KLF10/11 but incomplete R1 and R2 domains (38). Examination of effects of cbt 
mutation revealed that the protein is capable of positively regulating the activity of 
different TGF- signals and mediating crosstalk between different pathways in the 
control of cellular differentiation and proliferation, a function completely conserved in its 
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 human counterparts (37). Additionally, cbt is downstream of forkhead (fkh), target of 
rapamycin (TOR) signaling, and, potentially, insulin/PI3K signaling. Knockdown of cbt 
via RNAi resulted in increases in cells size and proliferation, indicating a potential 
growth suppressive function for the protein (39). Under conditions of dietary protein 
depravation, fkh translocates to the nucleus, activating growth-inhibiting cbt, which 
subsequently executes a growth suppressive program through a regulation of a network of 
genes (40). A similar growth suppressive function has been described by KLF11 in 
human pancreatic epithelial cells in response to TGF- induction, a process disrupted in 
neoplastic transformation (41). The conservation of structure and function from 
invertebrate to vertebrate provides compelling evidence of the critical function of KLF 
proteins in the regulation of expansive, non-linear, highly interdependent gene networks 
in metabolism, growth, and cellular differentiation; functions exquisitely sensitive to 
environmental input.  
 
Cbt homologs are found across a wide variety of vertebrate and invertebrate species, but 
are notably absent from nematodes (38). C. elegans, however, possesses three known 
KLF homologs, suggesting that the current family of human KLF homologs has multiple 
ancestral genes, indicating early expansion events. Drosophilia possesses six KLF 
homologs (42).  Luna, CG12029, CG9895 correspond to KLF6/7 (43), KLF5, and 
KLF3/8/12, respectively. Bteb2 and cabut correspond to KLF15 and 
KLF9/10/11/13/14/16, respectively.  The remaining two homologs, CG3065 and khb, 
appear to be unique to Drosophila. KLF17 similarly appears as a unique post-speciation 
event. Examination of the Daphnia genome reveals homology between five KLF 
homologs, KLF1A-E, and human KLF1/2/4, suggesting an independent vertebrate 
expansion. Despite rapidly divergent amino acid identities, function is highly conserved 
within the paralog clusters in vertebrates descended from their invertebrate orthologs 
(44). These data indicate high evolutionary pressure for strict conservation of DNA-
binding capability with selective conservation of amino terminal domains to retain 
primary function while diverging rapidly post-speciation to adapt to the increasing 
complex regulatory demands of higher order organisms.  
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KLF proteins target epigenetic information to gene promoters to regulate gene 
expression  
No single classification scheme may accurately characterize the function of any KLF 
member in its entirety. However, the classification of family members by virtue of their 
co-factors provides a framework to understand the functional differences between KLF 
subfamilies and the manner in which they engage chromatin to activate or repress 
transcription in a dynamic and reversible manner. KLF proteins deliver epigenetic 
information to gene promoters through three primary mechanisms: (i) sensing and 
translating environmental stimuli into a program of gene expression, (ii) sequence-
specific targeting of chromatin remodeling complexes to gene promoters, and (iii) 
transactivation of other transcription factors to assist in the regulation of large networks 
of interdependent genes. Transient regulation of gene expression occurs through 
association with histone acetyltransferases (HATs) and histone deacetyltransferases 
(HDACs), while long-term gene silencing is enacted by interactions with histone 
methyltransferases (HMTs) and DNA methyltransferases (DNMTs). 
 
Mechanism I: Translating internal and external input into gene regulation (Figure 
2A) 
KLF/Co-activator interactions: HATs, p300, CBP, and PCAF  
Several members of the KLF family interact with co-activators to promote transcription. 
As described above, the chromatin landscape largely governs the accessibility of DNA 
sequences to transcription factors. As such, besides physical interaction between KLF 
protein and DNA sequence, the recruitment of co-activators to gene promoters is critical 
to the remodeling of chromatin to a permissive state. KLF proteins primarily restructure 
chromatin at target binding sites via recruitment of proteins that possess histone 
acetyltransferase (HAT) activity, such as E1A binding protein (p300) or CREB-binding 
protein (CBP). Together with acetylase p300/CBP associated factor (PCAF), p300 and 
CBP interact with numerous transcription factors (45). Histone acetylation at target 
promoters provides docking sites for “reader” molecules via a bromodomain designed to 
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recognize acetylation modifications (46). For instance, the ATPase unit of the SWI/SNF 
chromatin-remodeling complex contains one bromodomain. Action of bound SWI/SNF 
results in physical remodeling of nucleosome position along a stretch of template, 
permitting entry of transcriptional factors. p300/CBP and PCAF also acetylate other 
transcription factors, the effect of which is postulated to influence their stability and 
interaction with other protein in a manner similar to protein phosphorylation (47,48).  
 
KLF/Co-repressor interactions: HDACs, Sin3, and CtBP  
Concurrently in 1998, two groups codified the primary functional subfamilies of KLF 
repressors utilizing the divergent interactions with its then identified co-repressors as a 
system for division. Our laboratory described the TGF--inducible (TIEG) subfamily of 
repressors that operates through the Sin3/HDAC (histone deacteylase) system (17,32,34), 
while Turner and Crossley reported a subfamily that utilizes the C-terminal-binding 
protein (CtBP) co-repressor (49). Our group further characterized an extended family of 
Sin3/HDAC repressors—the basic transcription element-binding proteins (BTEBSs) 
(50,51)—based on structural similarity, although the TIEG and BTEB subgroups are 
functional indistinguishable.  
 
The CtBP-dependent KLF repressors include KLF3, KLF8, and KLF12, which contain a 
five amino acid motif, PXDLS, which mediates interaction with CtBP (49,52,53). The 
degree of dissimilarity in the N-terminus between these three factors is high, such that the 
CtBP binding motif is the only point of conservation. The mechanisms by which CtBP 
proteins effect transcriptional repression in concert with their KLF partners are not fully 
characterized.  One method of action may be through the recruitment of HDACs (54,55), 
although HDAC-independent repression through the recruitment remodeling complexes, 
such as Ikaros and members of the Polycomb complexes has been observed (54,56-58). 
The context in which CtBP recruits additional co-factors is unknown. As abolishment of 
CtBP binding through mutation of the PXDLS motif only partially abrogates the 
repressive function of KLF3 and KLF8, suggesting additional critical co-repressors 
(53,59). However, gene silencing appears to occur through rearrangement or alteration of 
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nucleosomes as nearly all identified interactions are with critical components of 
chromatin-remodeling complexes designed toward chromatin compaction and 
transcriptional repression. 
 
The Sin3-dependent KLF repressors substantially characterized by our group are 
comprised of the TIEG and BTEB subfamilies, namely KLF9, KLF10, KLF11, KLF13, 
and KLF16, which utilize the HDAC system to execute gene repression through direct 
interaction with the scaffold co-repressor protein Sin3 (60). Sin3 proteins constitute large 
scaffolds with multiple protein interaction domains to permit assembly of large, often 
heterogeneous complexes with the ability to mediate repression through its associated 
subunits, which include HDAC1, HDAC2, RBAP46/18 (retinoblastoma protein (Rb)-
associated proteins 46/48), among others (61). Sin3 mediates interaction between KLF 
and other transcription factors through four evolutionarily conserved imperfect repeats of 
~100 residues each which are predicted to form a four-helix-bundle fold, known as a 
paired amphipathic helix (PAH) region (60,61). KLF16 is capable of executing 
repression through interactions with all three Sin3 isoforms and the HDAC system, 
suggesting even higher levels of plasticity in chromatin co-factor selection than 
previously realized (60).  
 
Initial biochemical characterization of KLF10 and KLF11 revealed that the N-terminus of 
each possess three distinct transcriptional repressors domains, R1, R2, and R3 (32). 
Secondary structure predictions indicated that the R1 domain would adopt an -helical 
conformation, which was later confirmed by circular dichroism analysis (34). Proline 
mutations within this domain significantly disrupted its repressive activity and 
subsequent binding studies uncovered Sin3a as the high affinity binding protein at this 
site (32,34). The core R1 domain was characterized as the SID (Sin3-interacting domain) 
motif and found to bind to the PAH2 domain of Sin3a to effect gene repression. KLF9, 
KLF13, KLF14, and KLF16 display conservation of the SID and execute gene repression 
through remodeling of chromatin marks via HDAC-mediated alterations to surrounding 
nucleosomes (32,34,50,51). KLF1 also interacts with Sin3a but lack an N-terminal SID, 
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interacting instead through its zinc finger domain (62). For instance, TGF- pathway 
activation leads to the recruitment of KLF14-Sin3a-HDAC repressors complex to the 
TGFRII promoter, resulting in reductions in activating histone acetylation marks and 
increases in marks associated with transcriptional silencing, i.e. methylated H4-K20 (63).  
 
Efforts to determine the interacting partners for the R2 and R3 domains of KLF11 have 
revealed additional interactions in transient gene regulation. For example, structural 
analysis of the R2 domains predicts the formation of a second, SID-like -helical patch. 
Yeast two-hybrid results indicate strong binding affinity for RNA-recognition-motif 
(RRM) proteins responsible for splicing of primary mRNA following transcription 
(Urrutia, unpublished data). This data places KLF in intimate connect with transcriptional 
machinery and suggests a host of other novel functions in the regulation of gene 
expression that await characterization. 
 
KLF/HMTS and DNMTs 
Two systems predominate for instituting a repressive chromatin landscape in long-term 
gene silencing: Polycomb and Heterochromatin-associated Protein 1 (HP1). As opposed 
to the dynamic regulation of transcription by the activity of HATS and HDACs, HP1 and 
Polycomb proteins lead to permanent silencing through the activity of histone 
methyltransferases (HMTs). HP1 is one of the epigenetic “reader” molecules that serve as 
“gatekeepers” of silencing by recognizing methylated lysine 9 marks on histone 3 (H3-
K9me) via its chromodomain and chromoshadow domains (64-66). Current knowledge 
supports a paradigm whereby HP1 proteins repress gene expression by binding to 
H3K9me marks and interacting to H3K9 HMTs, such as G9a or SUV39H1, which 
methylate this residue on adjacent nucleosomes thereby compacting chromatin and 
silencing gene expression (67,68). Thus far, this phenomenon has primarily been 
assumed to occur independently of sequence-specific DNA sites. HP1 remodels 
chromatin through interactions with HP1-binding proteins containing a consensus 
sequence, PxVxL, or in a PxVxL-independent manner (69-71). Our data demonstrated 
that the HP1 isoform interacts with KLF11 through its PxVxL domain within the 
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extreme C-terminus of the protein (72). HP1 recruitment to the CXCR4 promoter 
occurred in the presence of wild type KLF11 but not with KLF11 with deletion of the C-
terminal HP1-binding site (KLF11ΔHP1). Failure to recruit Notably, the recruitment of 
SUV39H1 is contingent on the integrity of the KLF11-HP1 complex since this HMT was 
absent with KLF11ΔHP1. These results demonstrate that HP1α-SUV39H1 recruitment is 
dependent on KLF11 sequence-specific promoter binding and underscores the 
functionality of this recruitment in long-term gene silencing of gene targets. 
 
Polycomb proteins may be divided into two categories, the components of Polycomb 
Repressive Complex 1 (PRC1) and Polycomb Repressive Complex 2 (PRC2). The 
enzymatic engine of PRC2 is EZH2 (enhancer of zeste homologue 2), which possesses 
the SET domain that confers the complex with its methyltransferase activity (73-76). The 
H3-K27me3 mark imprinted by PRC2 subsequently serves to recruit PRC1, a large, 
heterogeneous complex that contains chromodomain-containing CBX proteins 
responsible for recognition of trimethylated H3-K27 (77). PRC1 functions to maintain the 
repressive state initiated by PRC2, although the mechanisms by which PRC1 
accomplishes this task are unclear. Repression may be mediated through the recruitment 
of other chromatin-remodeling enzymes, specifically DNMTs and HDACs (78-82). 
PRC1 can restrict access of chromatin remodeling or transcriptional machinery to the 
DNA template, as evidenced by the ability of PRC1 to hinder ATP-dependent SWI/SNF 
remodeling (83,84). In Drosophila, Spps, a KLF family protein is critical to the 
recruitment of Polycomb complexes to gene promoters (85). Interactions between CtBP 
and vertebrate Polycomb homologs (related to PRC1 components) have also been 
observed in Xenopus through a six amino acid conserved motif in CtBP (58). 
Furthermore, our collaborative group has described an antagonistic relationship between 
the KLF10-PCAF pathway and PRC2 function in the regulation of the FOXP3 promoter. 
In the absence of KLF10, PCAF is not recruited to the FOXP3 promoter, resulting in a 
lack of H4 acetylation and a persistent block in FOXP3 transcription, resulting in a 
failure of adaptive Treg cells (86). The recruitment of PRC2 through binding of another 
KLF family member, similar to recruitment via Spps in Drosophila, is hypothesized, as is 
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the involvement of DNMTs to solidify the repressed chromatin state. These data describe 
for the first time a role for KLF proteins in guiding long-term gene repression and 
transcriptional memory. 
  
Regulation of KLF proteins and pleiotropic effects 
A wealth of evidence indicates that a large measure of ambiguity exists within the current 
classification of KLF repressors and activators, with the majority KLF protein displaying 
some degree of pleiotropic effects, i.e. activation when a factor typically mediates 
repression and vice versa. For instance, KLF1, the well-characterized erythroid-specific 
activator of the -globin gene displays a repressive function under certain contexts (16). 
However, in its repressive function, KLF1 is not recruited via its DNA-binding domain to 
gene promoters but through association with other DNA-binding proteins and is capable 
of association with the Sin3-HDAC system (62). Another example is KLF13, which 
activates several promoters, including SV40, RANTES, and -globin, but represses 
others, such as CYP1A1 (50,87-89). Given our incomplete understanding of the entire 
array of co-repressor and co-activator interactions, it is reasonable to speculate that all 
KLF family members are capable of activation or repression in a context-dependent 
fashion. 
 
The mechanisms by which these factors selectively recognize associated co-repressors or 
co-activators to determine their function remains purely conjecture. Promoter context, to 
be discussed in the following section, is likely to play a large role. Additionally, KLF 
proteins are capable of undergoing a variety of posttranslational modifications, including 
acetylation, phosphorylation, ubiquitination, and SUMOylation, that alters their 
transcriptional activity through modulation of binding affinity downstream of signaling 
pathways (reviewed in detail in (90)). Our laboratory and collaborators described a novel 
pathway in which phosphorylation of KLF11 by extracellular signal-regulated kinase 
(ERK)/mitogen-activated protein kinase (MAPK) abrogates the interaction with Sin3a 
and inhibits repression of Smad7 (91). Furthermore, we demonstrated that KLF11 inhibits 
prostaglandin E(2) synthesis through transcriptional silencing of its biosynthesis enzyme, 
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cytosolic phospholipase A2alpha. KLF11 accomplishes this repression through 
recruitment of the Sin3 remodeling complex, an interaction interrupted by epidermal 
growth factor receptor-AKT-mediated phosphorylation at T56, within the SID (92). 
Phosphorylation of Y10 of KLF16, potentially by Src tyrosine-kinase, also disrupts its 
binding with Sin3a, disruption repression of CYP1A1, affecting estrogen metabolism and 
uterine pathobiology (60). Like KL11, KLF16 regulation is directed downstream of 
cellular signaling rather than being constitutive (60,93). The diverse array of pos-
translational modifications and the complex network of protein-protein interactions 
permit precise, yet dynamic regulation of gene promoters channeled through KLF. 
Regulation of KLF affinity through posttranslational modifications provides a direct link 
from environmental induction of signaling cascades and the delivery of epigenetic 
information to gene promoters by influencing interactions with co-factor chromatin 
remodeling complexes. Disruption of these associations is a prime mechanism in the 
development of complex disease phenotypes.  
 
Mechanism II: Sequence-specific targeting of chromatin remodeling complexes 
(Figure 2B) 
Posttranslational modifications of KLF proteins only partially resolves the conundrum of 
what determines the selective interactions with co-activators or co-repressors that defines 
their function at a given gene promoter. In describing one of the first known KLF factors, 
Imataka observed that KLF9 could activate transcription if a promoter element contained 
multiple GC boxes but behaved as a repressor on promoters containing only a single copy 
of the sequence (13). For decades, the transcriptional field focused on characterizing and 
cataloguing the consensus sequences of binding sites, holding tight to the paradigm of a 
single binding site as the ultimate, passive determinant in the binding of a transcription 
factor. Two exciting discoveries of our laboratory support the notion that regulation of 
gene expression by KLF proteins is highly dependent on promoter context. In this 
paradigm, KLF binding and function is determined by both the KLF binding sites as well 
as neighboring transcription factor binding sites, forming a cis-regulatory element or 
block. 
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Polycomb Response Elements (PREs) 
In Drosophilia, Polycomb remodeling complexes are recruited to gene promoters through 
specific cis-regulatory domains known as Polycomb Response Elements (PREs), which 
contains clusters of DNA binding sites for Polycomb proteins. The relationship between 
KLF proteins and Polycomb in Drosophila is extensive. Early studies in Drosophila 
identified the importance of both Krüppel and Polycomb as critically relevant to 
regulation of the homeotic gene Scr (Sex combs reduced) (94). Subsequent work on a 
homeotic gene within the bithorax complex Abdominal-B provided evidence for a 
generalized model of gap gene products (Krüppel) promoting stable silencing through 
Polycomb in homeotic Drosophila genes (94). Perhaps the greatest revelation, however, 
has been the report that KLF binding sties are present in the majority of Drosophila PREs 
and that binding of Spps, a KLF protein, is necessary for the full activity of PREs (85,95). 
 
Identifying mammalian PREs has proven difficult, as the majority of the recruitment 
machinery is not conserved from Drosophila. KLF10 knockout mice display impaired 
FOXP3 activation with impaired adaptive T regulatory cell differentiation (96). 
Chromatin immunoprecipitation (ChIP) studies revealed that in KLF10-/- mice, the 
FOXP3 promoter is occupied by EZH2 with subsequent increases in H3-K27 
trimethylation (86). We hypothesized that silencing of FOXP3 by Polycomb is a default 
mechanism that must be overcome by KLF10 to achieve an inducible state. 
Bioinformatics analysis of the mammalian FOXP3 promoter element revealed binding 
sites for KLF proteins, Yin Yang 1 (YY1), the vertebrate ortholog of Drosophila Pho, 
and GAGA factor (GAF), the ortholog of Pipsqueak. Introduction of this promoter 
element fused with luciferase into an epithelial cell line resulted in progressive silencing 
of luciferase expression. Subsequent studies detailed a mechanism by which 
KLF10/PCAF antagonizes the function of PRC2, resulting in increased acetylation and 
induction of FOXP3 expression (86). The potential for other KLF factors to bind and 
modulate the activity of mammalian PREs is an area of active investigation.  
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HP1 Response Elements (HREs) 
Elegant studies have previously demonstrated KRAB (Krüppel-Associated Box)-
containing zinc finger transcription factors recruit KAP1 (KRAB-ZFP Associated Protein 
1), which binds to HP1 through a transcriptional intermediate, KAP1. On the other hand, 
KLF11 binds to its target DNA sequence regardless of whether it is bound or not to HP1. 
The two obvious differences indicate that the biophysical and biochemical properties that 
regulate these two mechanisms for recruiting HP1 to promoters are readily distinct. In an 
elegant biochemical study, Lomberk demonstrated that an extended KLF11 binding site 
(CCGCCCCGCCCC) mediates the sequence-specific recruitment of HP1-SUV39H1 to 
promoters with an associated increased in H3K9me3 marks (72). HP1 triggers this 
function by being recruited to promoters in a sequence-specific manner rather than its 
well-characterized binding to methylated chromatin, indicative of how this system can 
function in the regulation of gene expression with a higher degree of specificity.  
Sequence analysis of a subset of gene targets affected by the uncoupling of KLF11 from 
HP1 reveals that in addition to conservation of the extended KLF11 binding site, the gene 
promoters share 100-200bp regions of similarity centering around the KLF11 binding site 
(Lomberk and Urrutia, unpublished data). Similar to the KLF-PRE described here, the 
KLF HP1 Recruitment Elements (HREs) are comprised of binding sites for other 
transcription factors, indicating that additional combinatorial effects, besides those 
critically mediated by KLF proteins, may modulate the recruitment of both HMT systems 
to promoters.  
 
Disruption of the interaction between KLF11 and HP1 via mutation results in the 
deregulation of a large network of genes related to the regulation of cell death, 
proliferation, and senescence, consistent with KLF11’s previously characterized role as a 
tumor suppressor (72). A subsequent study probed further into the relationship between 
KLF11 and HP1 in the regulation of neuronal differentiation networks. We demonstrate 
that KLF11 binds to a distinct KLF site within the Drd2 promoter and recruits p300 
histone acetyltransferase to activate its expression (97). Disrupting the interaction 
between KLF11 and HP1 further enhances Drd2 transcriptional activation, indicating that 
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the interplay between these two pathways functions as a rheostat to maintain appropriate 
levels of Drd2.  
 
Overall, the discovery of this KLF11-mediated HP1 recruitment mechanism, together 
with the knowledge of KLF-PREs, suggests that KLF sites have undergone evolutionary 
pressure to maintain their ability to recruit potent HMT-based silencing complexes. 
Furthermore, the observation that KLF can work via histone acetylation (p300), 
deacetylation (Sin3a), and histone methylation (HP1), as described above, indicates that 
this sequence-specific transcription factor has many functions which occur via different 
pathways or alternatively, that several pathways are required for the same function. In 
addition, it is interesting to consider the convergence of short-term (Sin3a) and long-term 
(HP1) repression mechanisms on the same KLF molecule. Dysfunction of mechanisms of 
long-term repression precipitates the permanent silencing of critical genes through 
aberrant histone methylation or DNA methylation. For instance, in pancreatic cancer, the 
p16 tumor suppressor is effectively knocked out due to hypermethylation of the 
CDKN2A promoter (98). The possibility that KLF proteins may effect long-term gene 
silencing of gene targets opens a previously unexplored pathway by which these factor 
may lead to constitutively activated or repressed genes, blurring the line between “soft” 
and “hard” inheritance even further. 
 
Mechanism III: Transactivation of other transcription factors and cross-regulation 
within the KLF family (Figure 2C) 
Amplification of membrane-to-nucleus signaling requires multistep induction of cascades 
of gene expression. The activation of one transcription factor induces the expression of 
other transcription factors, resulting in exponential amplification of the initial signal as 
well as a high level of control in fine-tuning expression of large, highly interdependent 
networks of genes downstream of the initial activation point. Recent evidence suggests 
that some if not the majority of KLF proteins occupy a position at the apex of signal 
transduction cascades, modeling the activity of potent downstream transcription factors to 
significantly expand and diversify its repertoire of gene targets. 
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Instances of modulation of downstream transcription factor pathways through KLF with 
“local” effects abound. Transforming growth factor- (TGF-) is a pleiotropic cytokine 
that regulates a large number of cellular processes, including cell growth, apoptosis, 
differentiation, migration, and metastasis (99). TGF binds to its transmembrane receptor 
kinase complex to induce Smad signaling molecules, which translocate into the nucleus 
to regulation transcription. KLF10 and KLF11 were TGF-inducible factors cloned and 
characterized in our laboratory to function as effector proteins in the control of cell 
growth and differentiation (18,32,41,100). Nuclear interaction of Smad3 and KLF11 
results in the repression of the c-Myc oncogenic transcriptional factor, attenuating 
downstream cascades initiated by Myc. Furthermore, KLF11 inhibits Smad7, breaking 
the negative feedback loop on the expression of TGF and amplifying Smad-mediates 
signaling. A similar function has been observed in the ability of KLF4 and KLF5 to 
modulate immune response in the gastrointestinal tract, where both transcriptional factors 
are highly enriched. KLF5 is activated through the MAPK and ERK1/2 pathways 
downstream of lipopolysaccharide (LPS) exposure, a bacterially-derived endotoxin (101-
103). LPS activation of transmembrane toll-like receptors (TLRs) leads to induction of 
MAPK signaling, activation of KLF5, and the subsequent KLF-dependent activation of 
the NF-B transcription factor expression, eliciting a proinflammatory cascade response 
(103). KLF has been demonstrated to regulate other transcription factors, including 
PPAR (104,105).  Furthermore, high-throughput screening methods (microarray, RNAi, 
ChIP-seq, GWAS, among other) have revealed the ability for KLFs to regulate much 
larger cascades of transcription factors than previously imaged (Figure 3). 
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FIGURE 1. Structure and evolution of the KLF family of transcription factors. A. Structural domains 
of the human KLF protein family. B.  Differential evolution of the variable C and invariant N terminals of 
KLF proteins from fly to human.  C. Evolutionary conservation of ancesteral gene cabut to KLF 
descendants.  
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FIGURE 2. Mechanisms of the delivery of epigenetic information to gene promoters by KLF 
proteins. A. Sequence-specific recruitment of chromatin-remodeling complexes by KLF proteins by 
coupling of KLF11 to HATs (A) in transient activation, HDACs in transient repression (B), and HMTs in 
long-term gene silencing (C). 
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SUMMARY 
The function of Krüppel-like Factor 11 (KLF11) in the regulation of metabolic pathways 
is conserved from flies to human. Alterations in KLF11 function result in MODY VII and 
neonatal diabetes, however, the mechanisms underlying the role of this protein in 
metabolic disorders remain unclear.  Here, we seek to investigate how the MODY VII 
A347S genetic variant, present in patients with juvenile diabetes, modulates KLF11 
transcriptional activity. A347S affects a previously identified transcriptional regulatory 
domain 3 (TRD3) for which co-regulators remain unknown. Structure-oriented sequence 
analyses, described here, predict that the KLF11 TRD3 represents an evolutionarily 
conserved protein domain. Combined, yeast two-hybrid and protein arrays demonstrate 
that the TRD3 binds WD40, WWI, WWII, and SH3-domain containing proteins. Using 
one of these proteins as a model, guanine nucleotide binding protein beta 2 (G2), we 
investigate the functional consequences of KLF11 coupling to a TRD3 binding partner. 
Combined, immunoprecipitation and biomolecular fluorescence complementation assays 
confirm that activation of three different metabolic GPCR receptors ( -adrenergic, 
secretin and CCK) induce nuclear translocation of G2 to directly bind KLF11 in a 
manner that is disrupted by the MODY VII A347S variant. Using genome-wide 
expression profiles, we identify metabolic gene networks impacted upon disruption of the 
TRD3. Thus, this study characterizes a novel protein-protein interaction domain disrupted 
in a KLF gene variant that associates to juvenile diabetes, contributing to our 
understanding of gene regulation events in complex metabolic diseases. 
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INTRODUCTION 
KLF11, a human ortholog of the Drosophila gene cabut, belongs to the Krüppel-Like 
Family (KLF) of transcription factors. Members of this family regulate GC-promoters in 
organisms ranging from flies to humans (106). Rapidly emerging evidence demonstrates 
that these cabut/KLF pathways regulate important metabolic processes conserved in 
organisms ranging from flies to humans (38). For instance, cabut is a transcriptional 
regulator of metabolic gene pathways in Drosophila (40,107). Disruption of KLF 
pathways leads to biochemical alterations and metabolic impairment, often resulting in 
lethality. In fact, human variants in the KLF11 protein (MODY VII) as well as on its 
DNA binding site within the insulin promoter cause juvenile and neonatal diabetes, 
respectively (108,109). Moreover, extensive studies have demonstrated KLF11 binds and 
regulates many promoters of genes involved in cholesterol, prostaglandin, 
neurotransmitter, fat, and sugar metabolism (108-114). Thus, the medical significance of 
this knowledge led us to study how alterations in KLF11 proteins impact the regulation of 
metabolic gene networks of relevance toward better understanding of complex human 
diseases.  
 
KLF11 is a well-characterized protein in terms of its ability to couple to several 
chromatin pathways and epigenetic regulators, including Sin3a, histone acetyltransferase 
(HATs), and HP1 (34,115,116). The following study has been designed to further our 
mechanistic understanding of how disease-associated alterations that affect the 
membrane-to-nucleus coupling of KLF11 to the regulation of metabolic genes. Contrary 
to the variants in KLF11 DNA binding sites, which have the power to uncouple a single 
gene promoter (e.g. c.-331 INS variants) (108), alterations in chromatin coupling can 
disrupt complex functions, such as metabolism, by altering the expression of entire gene 
networks. Interestingly, variants that fall near the Sin3a domain alter the ability of KLF11 
to regulate metabolic target genes and associate with MODY VII (109). The KLF11-
mediated HAT pathways appear to impact the regulation of insulin in neonatal diabetes 
(108). However, the mechanisms and function of other KLF11 mutations that associate 
with diseases remain to be characterized. Thus, studying these types of alterations can aid 
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in better defining the identity of KLF11-mediated metabolic gene networks, the 
mechanisms of their regulation, and the mechanisms that inactivate these pathways in 
humans.  
 
The KLF11/MODY VII A347S variant found in juvenile diabetic patients (109) maps to 
a previously characterized transcriptional regulatory domain (TRD3), for which 
functional cofactors have remained unknown (117). In the current study, we demonstrate 
that the KLF11 TRD3 functions as a novel protein-protein interaction domain, which 
function is altered in the A347S diabetes variant. We further show that activation of cell 
surface receptors involved in metabolism (adrenergic, secretin, and CCK receptors) can 
induce the nuclear translocation of a TRD3 binding protein (G2) to bind KLF11 in order 
to regulate metabolic gene targets. Combined, these studies reveal the existence of a 
novel KLF-mediated pathway for coupling extracellular signals to the regulation of gene 
expression related to metabolism and diabetes. These findings extend our understanding 
of transcriptional regulatory events, which are disrupted in human metabolic diseases. 
 
EXPERIMENTAL PROCEDURES 
Tissue culture and reagents - Cell lines were obtained from the American Type Culture 
Collection (ATCC, Rockville, MD). Cells were cultured as described previously 
(118,119). CHO cells stably transfected with the Cholecystokinin (CCK) Receptor A 
(CHO-CCKAR) were grown as described previously (120). Isoproterenol, secretin and 
CCK were purchased from Sigma-Aldrich (St. Louis, MO). 
 
Plasmids and recombinant adenovirus - Standard molecular biology techniques were 
used to clone full length KLF11, KLF11-A347S, G2, as well as specified deletions into 
pcDNA3.1/His (Invitrogen, Carlsbad, CA), pCMV-Tag 2B (Stratagene, La Jolla, CA), 
pGEX (GE Healthcare, Piscataway, NJ), and EYFP vectors as previously described 
(34,70). QuickChange® Site-Directed Mutagenesis was performed as suggested by the 
manufacturer (Agilent Technologies, Inc, Santa Clara, CA). All constructs were verified 
by sequencing at the Mayo Clinic Molecular Biology Core Facility. Epitope-tagged 
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(6XHis-Xpress™) KLF11 and KLF11 A347S variant as well as empty vector (Ad5CMV) 
were generated as recombinant adenovirus in collaboration with the Gene Transfer 
Vector Core at the University of Iowa.  
 
GST pulldown assays, Immunoprecipitation and Western Blot - GST and GST fusion 
protein purification, in vitro translation, GST pulldown assays, immunoprecipitation and 
western blot were all done as previously described (70). Antibodies were used against the 
FLAG (Sigma) or His-Tag (OMNI D8; Santa Cruz Biotechnology, Santa Cruz, CA) to 
detect recombinant expression of KLF11, KLF11 A347S variant, and G2, endogenous 
G1/2 (Santa Cruz Biotechnology), HP1 (Millipore, Billerica, MA), Sin3a (Santa Cruz 
Biotechnology), or CBP (Abcam, Cambridge, MA). 
 
Algorithm For Identifying TRD3 - To identify putative evolutionarily conserved domains, 
the N-termini prior to the conserved zinc finger regions of cabut (Drosophila) and KLF1-
17 (Homo sapiens) were analyzed using a sliding window of 15 amino acids. Windows 
were scored for overall hydrophobicity using the Kyte-Doolite scale (121); polyproline 
helix conformations using experimental derived values (122); and overall proline, 
glycine, and glutamine content (PGQ index). Regions were screened via pairwise 
alignment with KLF10 and KLF11 for R1 and R2 domains to determine the N-terminal 
boundary. Pairwise alignments were performed using the MUltiple Sequence Comparison 
by Log-Expectation Program (MUSCLE) (123). Phylogenetic tree was constructed using 
Geneious Tree Maker (Biomatters Ltd, Auckland, New Zealand) with the following 
settings: BLOSUM62 Matrix, Global alignment with free gap ends, outgroup set to cabut.  
 
Genome-wide expression profiles - Pancreatic cells (Panc1) were plated at a density of 
106 cells and transduced with empty vector, KLF11, or KLF11-A347S (Ad5CMV).  RNA 
was prepared as previously described (124). Global gene expression profiling was carried 
out at the Microarrays Facility of the Research Center of Laval University CRCHUL 
utilizing the Affymetrix Human Gene 1.0 ST arrays (28,869 well-annotated genes and 
764,885 distinct probes). Intensity files were generated by Affymetrix GCS 3000 7G and 
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the Gene-Chip Operating Software (Affymetrix, Santa Clara, CA). Data analysis, 
background subtraction and intensity normalization was performed using Robust 
Multiarray Analysis (RMA) (125). Genes that were differentially expressed along with 
false discovery rate were estimated from t test (>0.005) and corrected using Bayes 
approach (126,127). Data analysis, hierarchical clustering, and ontology were performed 
with the OneChanelGUI to extend affylmGUI graphical interface capabilities (128), and 
Partek Genomics Suite, version 6.5 (Partek Inc., St. Louis, MO) with ANOVA analysis.  
The criteria of log2 fold change 1.5 and a p-value of <0.05 compared to empty vector 
control or wild type KLF11 levels were used to determine significant gene targets. A 
subset of genes was validated by qPCR as previously described (124,129).  The criteria of 
log2 fold change 1.5 and a p-value of <0.05 compared to empty vector control was used 
to determine significant gene targets. Hela cells were plated at a density of 106 cells and 
transfected with empty vector, G, or G fused in frame to 3 copies of the SV40 NLS 
(130).  RNA was prepared as previously described above. Global gene expression 
profiling was carried out by the Microarray core of Mayo Clinic utilizing the Affymetrix 
Human Genome U133 Plus 2.0 Array.   The criteria of log2 fold change 1.5 and a p-
value of <0.05 compared to empty vector control was used to determine significant gene 
targets.  
 
Chromatin immunoprecipitation (ChIP) - ChIP was performed as previously described 
(70,116,129,131) using antibodies against His-Tag (OMNI D8; Santa Cruz 
Biotechnology) to detect recombinant expression of KLF11 or endogenous G1-2 (Santa 
Cruz Biotechnology). Binding activity was derived using the NimbleGen human 
promoter hybridization system (Madison, WI).  Peaks were detected by searching for >4 
probes where signals were above the specified cutoff values (90% to 15%) using a 500bp 
sliding window along 5kb upstream of the transcriptional start site in human promoters.  
Each peak was assigned a score that is the log2 ratio of the fourth highest probe in each 
peak.  If multiple peaks are present, the peak nearest the TSS is reported.  Ratio data was 
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then randomized 20 times to evaluate the false discovery rate (FDR). Only peaks with 
FDR scores <0.2 were deemed high confidence binding sites and reported. 
 
Identification of TRD3 Binding Proteins using yeast two-hybrid system - As bait, the 
coding region of the KLF11 TRD3 (amino acids 273-351) was cloned into the pGBKT7 
plasmid of the Matchmaker system (Clontech). The integrity and expression of the fusion 
construct was confirmed by sequencing. No autoactivation of the reporters was associated 
with this bait construct, as determined by cotransformation of the bait with prey library 
vector in host AH109 cells. Sequential library scale transformations were performed from 
a normal bone marrow cDNA library. A total of 2.5 million clones were screened and 
selected on high-stringency plates (SD/–Ade/–His/–Leu/–Trp) coated with X-β-Gal. 
After incubation for a period of 72–96 hours at 30°C, colonies were recovered and DNA 
from each colony was extracted and sequenced. The cDNA inserts from yeast clones 
were amplified by PCR using primers 5′CTATTCGATGATGAAGATACCCCACCA 
(forward) and 5′GTGAACTTGCGGGGTTTTTCAGTATCTACGA-3′ and sequenced at 
the Mayo Molecular Biology Core Facility. In order to eliminate false positives, isolated 
library prey plasmids were transformed into Y187 yeast and crossed with AH109 yeast 
carrying either the empty plasmid or the bait plasmid; activation of the reporter gene was 
assessed by growth in SD -Trp/-Leu/-His, plus 3-AT.  
 
Identification of TRD3 Binding Proteins using Solid Phase Binding Assays - To screen 
for binding between the KLF11 TRD3 and SH3 or WW domain containing proteins, solid 
phase SH3 and WW domain arrays were obtained from Panomics (Fremont, CA) and 
processed according to manufacturer’s instructions utilizing 10-20g/ml of purified His-
KLF11 TRD3 (amino acids 273-351) for hybridization. 
 
Immunofluorescence and Bimolecular fluorescence complementation (BiFC) - CHO-
CCKAR cells were transfected with Flag-tagged or His-tagged G2 and KLF11 
expression constructs. The fluorescence was imaged using an LSM510 microscope 
(Zeiss, Heidelberg, Germany). For the BiFC analysis of individual cells by confocal 
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microscopy, HeLa and Capan2 cells were transfected with KLF11-EYFP1 and G2-
EYP2 expression vectors as previously described (70,116). 
 
RESULTS 
The KLF11 A347S variant maps to a protein interaction domain conserved in the KLF 
family of metabolic transcription factors. Previous studies in human populations have 
demonstrated that defined changes in the sequence of the KLF11 protein (Q62R, T220M 
and A347S) associate to early-onset type II juvenile diabetes mellitus (OMIM: MODY 
VII) (109). Functional studies demonstrated that these three KLF11 variants have 
impaired transcriptional activity compared to wild type. Subsequent studies focused on 
characterizing the mechanism of function for KLF11Q62R demonstrated that this protein 
is defective in binding to Sin3a, resulting in lower levels of insulin expression and 
promoter activity (109).  In contrast, here, our structure-oriented bioinformatics analyses 
demonstrate that the A347S variant falls within the regulatory domain 3 of KLF11 
(TRD3) and has the potential to disrupt the function of this domain for which cofactors 
have long remained to be identified (Figure 1A). Analysis of the KLF11 TRD3 sequence 
within the region affected in MODY VII (A347S) as well as the correponding region of 
its fly ortholog cabut, identified several proline-rich motifs (PRM, Figure 1B). PRMs are 
present in many transcription factors, chromatin regulators, and epigenetic proteins and 
facilitate protein-protein interactions (132). Interestingly, we find a high degree of 
conservation of these PRMs in all KLF proteins which are orthologues of the fly cabut 
gene, a known metabolic regulator (38). These human proteins form two KLF 
subfamilies, namely the TIEGs (KLF10 and KLF11) and BTEBs (KLF9, KLF13, KLF14, 
and KLF16) (106). The PRM motif identified in these studies displays key 
characteristics, falling into distinct structural types, two of them mark both the N-terminal 
(PRM1: PPØPØØØQØØP) and C-teminal (PRM4: GØXXØØPØØPØP) boundaries for 
the TRD3. Two other PRM domains are located centrally (PRM3: QØØPØPQPØØØGP 
and PRM3: ØØPPPØPØØØ). All of the PRMs are embedded within a biochemical-
biophysical environment entirely provided by hydrophophic amino acids and few flexible 
residues such as G and Q. Notably, analyses of extensive available data from NMR, x-ray 
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crystallography, phage display experiments, and liquid-phase binding assays demonstrate 
that PRM of this type are highly enriched within bonafide protein-protein interaction 
modules (132-134). These repetitive PRM motifs are shared by several protein-protein 
interaction modules. Binding of PRMs to their partners is required to form structures that 
have more stable thermodynamic properties. Therefore, to guide further biochemical 
studies, we developed a computational model that defines this KLF protein-protein 
interaction domain (Figure 2A), which reveals that the TRD3 is located immediately 
upstream of the KLF DNA binding domain in the region affected by MODY VII A347S. 
Evolutionary analysis of the TRD3 region further demonstrates the high pressure for 
preservation of the domain between fly and human across the cabut-KLF family (Figure 
2B). Thus, combined these results support the prediction that the TRD3 domain functions 
as a proline-rich module that likely mediates protein-protein interactions, a hypothesis 
that we subsequently tested experimentally. 
 
In order to define potential binding partners for this protein interaction domain we 
utilized  both, the yeast two-hybrid system and domain-specific protein binding arrays.  
The bait for yeast two hybrid studies as well as the recombinant protein for hybridization 
to protein arrays were derived from the region of KLF11 encompassing the TRD3, 
consisting of amino acids 273-351. The advantage of utilizing these two distinct assays 
was to perform both unbiased (yeast two hybrid) and candidate-based (protein array) 
approaches to identify potential TRD3-interacting proteins. For protein array 
experiments, we used a high TRD3/bound array protein ratio (5/1) so that proteins from 
the array would capture different amounts of TRD3 according to their binding affinities, 
as detected by different intensities. Arrays also included both positive and negative 
controls. Thus, the intentities in the authoradiographs gave an indication of relative 
binding strengths. These experiments show that, the KLF11 TRD3 binds to several 
WD40-containing proteins, including Gβ1, Gβ2, WD40 Repeat Domain 6, and 
echinoderm microtubule associated protein like 2, in addition to SH3- (8 positives from a 
total of 38), WWI- (10 positives from a total of 34), and WWII-containing proteins (4 
positives from a total of 33) (Table 1). When analyzed, the potential TRD3 interactome 
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defined by both methods reveals a network of proteins which, similar to KLF11, 
participate the regulation of transcription. Furthermore, some of these factors, such as 
ITCH, have previously identified roles in the functional regulation of cabut proteins 
(KLF10) (135),  thus providing internal validation for our experiments. Interestingly, 
though with less conservation in overall domain structure,  TRD3-like domains are 
present in a large number of KLF proteins outside of the cabut subfamily (Supplemental 
Table 1), some of which have been shown to interact with proline-rich binding proteins 
such as Nedd4-like protein, WWP1, for KLF2 (136), as well as YAP and WWP1 for 
KLF5 (137,138). Thus, from these experiments, we conclude that cabut members, as well 
as other KLF proteins, appear to have undergone evolutionary pressure to conserve 
proline-rich domains that harbor the potential to regulate their function. Combined, these 
structural relationships led us to perform subsequent studies aimed at clarifying the 
biochemical properties and functional impact of the TRD3 interactions in the 
transcriptional regulation of metabolic gene networks focused on isolating those which 
are disrrupted by the MODY VII A347S variant. 
 
Membrane-to-nucleus signaling pathways regulate the KLF TRD3 binding domain 
For subsequent functional studies, we choose to study Gβ2 as a model for a TRD3-
interacting protein since this interaction was identified as our most represented candidate 
via several clones from the yeast two hybrid system.  This is functionally relevant since 
in this system protein-protein interaction occurs in the eukaryotic nucleus (yeast), the 
compartment in which KLF11 performs its function. Additionally,  the interaction of a 
few KLF proteins with SH3 and WW domains have been previously characterized (135-
139) but those with WD40-containing proteins, such as Gβ (140), remain unknown, 
increasing the potential novelty of our findings. Furthermore, Gβ is known to regulate 
cell signaling cascades that are critical for maintaining metabolic homeostasis, including 
in diabetes (141-143). In fact, genetic variants of these proteins have also been assocaited 
with the development of this disease (141,144). Previous reports have also shown that the 
Gβ subunits translocate to the nucleus and interact with other transcription factors, 
including fos and the glucorticoid receptor (GR) (145,146). Therefore, in order to 
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confirm the interaction between KLF11 and Gβ2 detected by our yeast two hybrid 
experiments, we initially performed in vitro binding assays using 35S-labeled Gβ2 and 
GST fusion protein of the KLF11 TRD3 (amino acids 273-351). We demonstrate that 
Gβ2 indeed binds the KLF11 TRD3 in vitro (Figure 3A). Furthermore, based upon the 
sequences recovered from the positive yeast two hybrid clones, we utilized deletions of 
Gβ2 to determine the region of this protein required for interaction with KLF11. These 
investigations reveal that binding with KLF11 is maintained by Gβ2 deletions containing 
a minimum of amino acids 209-340, as observed by positive GST-KLF11/35S-Gβ2 
interaction for Gβ2∆1-105, ∆1-120, and ∆1-208 (Figure 3B). However, interaction was 
not detected with the N-terminal regions encompassing G -214) or G -214), 
as well as Gβ2∆1-221 (Figure 3B), which presumably disrupts the protein in WD40 
repeat 5. Therefore, Gβ2 with intact WD40 repeats 5-7 is necessary for interaction with 
KLF11.  
 
We next investigated this interaction in cultured cells and whether the KLF11-G2 can 
transduce signals from the membrane to the nucleus. For this purpose, HeLa cells under 
basal were co-transfected with His-tagged full length KLF11 and either empty Flag 
control vector or Flag-tagged Gβ2. Upon immunoprecipitation of Flag-tagged Gβ2, 
KLF11 was detected (Figure 3C). This result was further confirmed by 
immunoprecipitation of Flag-tagged Gβ1, as this isoform of Gβ was also recovered by 
our yeast two hybrid assay, which corroborated binding to KLF11 (Figure 3C). To 
examine the influence of G protein-coupled receptor (GPCR) activation at the plasma 
-
adrenergic GPCR signaling, which regulates many functions in HeLa cells (147). 
Interestingly, a more robust immunoprecipitation of KLF11 was observed with Gβ2 upon 
isoproterenol treatment (Figure 3C). In order to visualize this interaction in living cells, 
we used BiFC by fusing the EYFP N terminus (EYFP(1)) to KLF11 and the EYFP C-
terminal portion (EYFP(2)) to Gβ2. These constructs were co-transfected in both HeLa 
and Capan2 cells and subsequently stimulated with isoproterenol or secretin (148), 
respectively, for 30min prior to fixation. Secretin is an agonist for the GPCR family 
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generally with high levels in Capan2 cells (148).  Interaction was detected in both cell 
types upon their respective physiological stimulus as evidenced by yellow fluorescence 
reconstitution. Fluorescence resulting from the KLF11-Gβ2 interaction was localized, as 
expected, in the nucleus as determined by nuclear DAPI co-stain (Figure 3D). Co-
expression of a negative control leucine zipper protein with either KLF11 or Gβ2 fused to 
their respective EYFP halves did not reconstitute fluorescence, confirming the 
fluorescence obtained is specific and devoid of background (data not shown). 
Representative panels of untreated HeLa or untreated Capan2 cells are also shown 
(Figure 3D). To complement these studies, we also utilized CHO cells stably transfected 
with the GPCR, CCK Receptor A (CHO-CCKAR) (120), and transiently transfected 
epitope-tagged Gβ2 and KLF11. Similar to the adrenergic and secretin receptors, the 
CCKAR is a well-known regulator of metabolic functions (149). In agreement with 
previous reports, we find that Gβ2 localizes to the membrane and cytoplasm in 
unstimulated cells (Figure 3E). However, upon CCK treatment of the CHO-CCKAR 
cells, Gβ2 translocates to the nucleus where it localizes with KLF11, suggesting that 
under these conditions they function in close proximity (Figure 3E). Therefore, several 
physiological stimuli of distinct GPCRs (isoproterenol, secretin and CCK), which trigger 
dissociation of beta/gamma heterodimers from the trimeric G-protein alpha-s/beta/gamma 
complex at the plasma membrane to allow downstream signaling, result in interaction 
between Gβ and KLF11 in the nucleus of three different cell types. Combined, these 
results not only confirm our yeast two hybrid experiments, but more importantly indicate 
that activation of GPCRs induce the translocation of the Gβ2 subunit, which by forming a 
complex with KLF11, likely regulates responses (e.g.  gene expression). 
 
Metabolic gene networks requiring coupling of KLF11 to cofactors via the PRBD are 
deregulated by the A347S variant 
Since the region of interaction between KLF11 and Gβ2 encompasses the A347S KLF11 
variant, previously identified in a family of individuals affected by MODY-diabetes 
(109), we examined whether this naturally occurring variant interferes with binding 
between these two proteins. Immunoprecipitation of KLF11-A347S demonstrates that 
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this variant disrupts its interaction with Gβ2 (Figure 4A). Notably, this effect is isolated 
to binding between KLF11 and Gβ2, as the variant does not affect the interaction of 
KLF11 with its other known co-factors, Sin3a, HP1 or CBP/p300 (Figure 4B). These 
results reveal that the KLF11-A347S variant is useful to define whether protein-protein 
interactions influence the function that KLF11 has in the regulation of metabolic gene 
expression pathways. Thus, we performed a genome-wide query using a whole genome 
Affymetrix expression profile (RaGene 2.0) in primary pancreatic beta cells transduced 
with empty vector control, wild type KLF11, or the KLF11-A347S variant to define 
genes, and in particular, metabolic gene networks that are regulated by KLF11 but altered 
via the A347S variant that interrupts the function of the KLF11 TRD3 (Figure 5A). 
Clustering of all significantly altered probes (p<0.05) revealed distinct clusters of genes 
regulated by KLF11. Detailed statistical and bioinformatics analysis identified 2275 
unique genes that significantly (p<0.05, fold change 2) associate with KLF11 
expression, while 1205 genes significantly associate with KLF11-A347S expression.  
 
Visually, clustering analysis reveals that in beta cells, expression of the KLF11-A347S 
variant results in a blunted activating or repressive effect compared to the effects of wild 
type KLF11, suggesting loss of function. To statistically confirm the disruptive effect of 
the A347 variant in beta cell function, Gene Ontology ANOVA analysis of the dataset 
was performed. KLF11 expression regulates clusters of genes related to the entire insulin 
response pathway, including glucose import, glycolysis, fatty acid metabolism, insulin 
secretion, calcium and potassium channels, MAPK activity, and PI3K activity, among 
others (Supplemental Table 2). Figure 5B represents the overall pattern of expression of 
32 genes related to the regulation of insulin secretion following 48 hours of adenoviral 
mediated overexpression of KLF11, which mimics glucose exposure.  A given 
ontological cluster, is must be noted, may be comprised of both positive and negative 
regulators of insulin secretion, as well as associated co-factors and upstream/downstream 
effectors.  As such, the relative relationships between conditions hold more informative 
value than the direction of net effect.  Compared to empty vector control, expression of 
KLF11 results in a net, significant (p<0.05) repression of the targets within the group.    
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In the presence of the KLF-A347S variant, however, the expression of these genes is 
significantly and globally disrupted.  A small subset of other glucose and insulin related 
biological processes significantly deregulate din the presence of the A347S mutant are 
also shown (Figure 5B).  These insights into the transcriptional effects of the MODY VII 
A347S variant are congruent with the defects in insulin secretion and response observed 
in the patient population.   
 
To validate the regulatory effects of KLF11 and the KLF11-A347S variant observed in 
the genome-wide array, we performed qPCR on beta cells (Figure 4C) for a panel of 
insulin secretion and response pathway markers identified as significantly regulated from 
the global expression analysis Targets such as X and Y, related to X and Y function, 
respectively, are significantly de-repressed in the presence of the KLF11-A347 variant.  
This validation indicates the overall reliability of the array in identifying patterns of gene 
regulation by KLF11 or its variant.   The effects of KLF11 and its A347S variant were 
also examined in human exocrine pancreatic epithelial cells (Supplemental Figure 1), 
which also revealed disruption of metabolic pathways associated to insulin response 
Additionally, we validated the regulatory effect of Gβ2 overexpression on a subset of 
identified KLF11-regulated targets in human exocrine pancreatic epithelial cells. Targets 
significantly regulated by KLF11 overexpression demonstrate similar activation or 
repression with overexpression of Gβ2 fused to a 3X SV40 nuclear localization signal 
(Figure 6A), indicating co-operative regulation of the targets by these two molecules. 
Lastly, using ChIP assay we confirm that human gene promoters may indeed be co-
occupied by both KLF11 and Gβ within the first 5kb of their promoters (Figure 6B). 
Combined, these data support co-occupancy and regulation of gene targets by this newly 
identified KLF11-G2 transcriptional complex. 
 
DISCUSSION 
While the strength of modern genetics is to discover association of genes and their 
variants to disease which high level of resolution, significantly less is known on how the 
protein products work to give rise to diseases.  This has been the case with those genes 
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within the KLF family of transcriptional regulators, such as KLF11 and KLF14, which 
have been strongly associated to diabetes, obesity, and the insulin resistance/metabolic 
syndrome (108,109,150-152). For instance, very little is known as how these genes 
influence metabolic function.  The current study provides mechanistic insights into how 
human diabetes-associated genetic mutations and variants that occur in these metabolic 
transcription factors, such as the KLF11 A347 variant, impair the regulation of metabolic 
gene networks. In addition, we provide biochemical and genetic evidence for the 
existence of a novel transcriptional regulatory pathway that appears to translate 
membrane-to-nuclear signals such as those imparted by signaling proteins, in particular 
the G subunit, to the KLF11-mediated regulation of gene expression patterns relevant to 
metabolism and diabetes.   
 
The functional importance of the region corresponding to the KLF11 TRD3 was 
suggested in 1999 through a careful mapping of the N-terminal domain of this protein 
(117), though the identity of a potential cofactor for this domain has remained elusive. 
Thus, the identification of the TRD3 as a protein interaction domain has increased our 
mechanistic understanding of how KLF11 regulates its functions and how the MODY VII 
A347S variant impairs it. The TRD3 functions as a protein-interaction module as 
demonstrated by yeast two hybrid, protein array, immunoprecipitation, and BiFC 
experiments. In addition, we confirm that the Gβ subunit of the heterotrimeric G protein, 
the most represented candidate from our yeast two hybrid screening, interacts with 
KLF11 via its TRD3 domain. Furthermore, we demonstrate that the MODY VII A347S 
variant disrupts binding to this protein. In addition, using a solid-phase in vitro binding 
assay (protein array), we show that the TRD3 domain can bind to several types of P-rich 
binding modules such as WWI, WWII, and SH3 domain containing 
proteins. Interestingly, some of these proteins, such as ITCH and Nedd4-like proteins, 
have been previously shown to bind to KLF transcription factors (135-137), at their C-
terminal domain, providing a cross-validation of our experiments. While these regions 
show less homology to the corresponding cabut-like TRD3 domain, nevertheless they 
display the structural and functional characteristics that suggest that binding to members 
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of these families of proteins immediately upstream of the KLF DNA binding domain is a 
wider mechanism of regulation for KLF transcription factors.   
 
The TRD3 binding proteins identified here are found in a wide variety of eukaryotic 
proteins that have a range of functions including adaptor/regulatory modules in signal 
transduction, pre-mRNA processing, cytoskeleton assembly, gene transcriptional 
activation and cell cycle control. Of further interest, Gβ is a WD40 repeat protein, a large 
protein family for which members are increasingly being recognized as key regulators of 
chromatin dynamics, transcription, and epigenetics (153,154). Among the diversity of 
WD40 domain function, a common theme has emerged that they collude as repeats to 
form β-propeller structures that acts as a platform for the stable or reversible association 
of binding partners. For instance, WD40 domains are overrepresented in HDAC and 
HMT complexes with well-known examples found in Groucho, Polycomb group protein 
EED, and WDR5 (153,154). The Gβ subunits, which have been here associated to 
KLF11, have also been reported to interact with other transcription factors, including fos 
and the glucorticoid receptor (GR) (145,146). In fact, analyses of the GR (a.a: 263-419) 
and fos (159-238), the regions from both of these transcription factors which are known 
to interact with Gβ, reveal remarkable similarities to the KLF11 TRD3, in that they 
contains proline-rich domains embedded within a sequence that is rich in hydrophobic 
(Φ) as well as flexible amino acid (G and Q). The WD-40 motif of Gβ may be essential 
for the GR interaction, as a Gβ structural analog RACK1 (receptor for activated C-kinase 
1) also binds GR (155). This sequence feature adds to the similarities that Gβ works with 
this steroid receptor and KLF11.  For example, activation of Gi-coupled somatostatin 
receptor in rat pituitary GH3 cells induces nuclear translocation, which works as a 
corepressor through the direct binding to the AF-2 domain of GR (145).  Similarly, we 
show that the activation of the 2 adrenergic receptor by isoproterenol or the secretin 
receptor by secretin induces the formation of the KLF11-Gβ2 complex in the cell 
nucleus.  Together, these results suggest that members of very distinct families of 
transcription factors can utilize the Gβ2 subunit in order to mediate their function in gene 
expression.  
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The observations described here are also of significant biological importance since the 
role of Gβ2 in the nucleus has remained elusive for many decades. Fortunately, the 
working model that emerges by the congruent association of all data described in this 
study as well as those available for the GR is that extracellular signals induce the binding 
of WD40 proteins to these transcription factors in order to regulate metabolic gene 
networks. Consequently, disruption of this mechanism should lead to alteration in the 
regulation of these networks, an effect that we observed experimentally and that is 
congruent with a role of MODY VII A347S in human diabetes.  
 
CONCLUSION 
In summary, the current study extends the available knowledge on KLF proteins and 
identifies a novel evolutionarily conserved protein-protein interaction domain, which is 
involved in the transcriptional regulation of metabolic gene networks.  The biochemical 
contribution of this work lies in the extensive characterization of this domain, 
identification of Gβ as a binding partner, and the role of this domain in the regulation of 
metabolic gene networks. Lastly, the fact that mutations in this pathway, which are 
known to cause juvenile diabetes, impact on the regulation of metabolic gene networks 
should be taken into consideration for understanding potential molecular mechanisms that 
contribute to disease phenotypes. 
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FIGURE 1.  KLF11 A347S variant maps to a novel hydrophobic-glycine-glutamine-proline rich 
domain that is observed in the correponding region of its fly ortholog cabut. A. Diagramatic 
representation of the location and composition of a conserved protein-to-protein interaction domain present 
in the human ortholog of the Drosophila protein cabut, KLF11. Polyproline-rich regions are underlined and 
denoted in red. The A347S variant found in a subset of MODY VII patients is identified by an asterisk (*). 
B.  Cabut and KLF11 were compared utilizing 15 amino acid sliding windows across the N-terminus of 
each protein prior to the conserved zinc finger domain and scoring for overall hydrophobicity using the 
Kyte-Doolite scale (20); polyproline helix conformations using experimental derived values (21); and 
overall proline, glycine, and glutamine content (PGQ index). The analysis reveals the presence of 
polyproline-enriched islands amid stretches of strongly hydrophobic residues. 
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FIGURE 2. The KLF11 TRD3 protein domain is conserved in the cabut family of metabolic 
transcription factors.  A.  Comparison of biochemical-biophysical structure of the proline-rich domain 
between cabut and KLF10/11, its two closest orthologs, along with their consensus, is shown at the top. A 
similar comparision is shown below, which also includes the related BTEB subfamily of KLF proteins 
(KLF9, KLF13, KLF14, and KLF16) and the corresponding consensus.  Regions with high polyproline 
content with either high hydrophobic character or high PQG index were deemed putative TRD3 domains.  
KLF11 contains four distinct PRM domains which are embedded within an environment of hydrophophic 
amino acids (Φ) and few flexible residues such as G and Q (green residues).  Proline residues are denoted 
in red. Represented regions include amino acids 108-155 for cabut, 268-348 for KLF10, 281-373 for 
KLF11, 31-123 for KLF9, 76-139 for KLF13, 29-177 for KLF14 and 30-100 for KLF16. B.  Evolutionary 
analysis reveals a high pressure for conservation of this protein domain from Drosophila cabut to human, 
with the closest orthologs that of the TIEG family of KLF proteins (KLF10 and KLF11). Members of the 
BTEB family of KLF proteins (KLF9, KLF13, KLF14, and KLF16) are also closely related. 
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FIGURE 3. Membrane-to-Nuclear coupling of the KLF11 TRD3 with the Gβ subunit of the 
heterotrimeric G protein.  A. Gβ2 binds the KLF11 TRD3 in vitro. GST-KLF11 TRD3 (a.a. 273-351) and 
GST alone were utilized for GST pulldown assays with 35S-labeled in vitro translated Gβ2. Phosphorimage 
results of 35S-Gβ2 binding (upper) and Coomassie staining of GST and GST-KLF11 TRD3 proteins as a 
loading control (lower) are shown. GST alone was included as a negative control. B. 
KLF11 binding requires Gβ2 WD40 repeats 5-7 in vitro. GST-KLF11 full length and GST alone were 
utilized for GST pulldown assays with various 35S-labeled in vitro translated Gβ2 deletions. Interaction 
between KLF11 and Gβ2 was not detected with the N-terminal regions encompassing Gβ2∆1-214) or 
Gβ2∆106-214). Positive interaction was detected for Gβ2∆1-105, ∆1-120, and ∆1-208. Gβ2∆1-221, which 
disrupts WD40 repeat 5, also does not interact with KLF11, indicating that Gβ2 needs intact WD40 repeats 
5-7 for binding. Upper panel shows phosphorimage results of 35S-Gβ2 binding (upper) and Coomassie 
staining of GST and GST-KLF11 proteins as a loading control (lower). Lower panel depicts a cartoon 
representation of Gβ2 with location of its WD40 repeats, as well as the various deletions used for mapping 
of the Gβ2-KLF11 interaction. C. Gβ binds to KLF11 in cells, which is enhanced by activation of GPCR 
signaling. Upon co-transfection of epitope-tagged Gβ2 and KLF11 in HeLa cells, Flag-tagged Gβ2 
immunoprecipitates His-tagged KLF11.  Empty vector (EV) was utilized as a negative control in 
combination with either Flag-Gβ2 or His-KLF11, separately. Immunoprecipitation of Flag-tagged Gβ1 also 
detected a complex with KLF11. Experiments with Flag-tagged Gβ2 or EV and His-tagged KLF11 were 
repeated in the presence of isoproterenol, which detected a more robust interaction. D. BiFC of KLF11 and 
Gβ2 demonstrates nuclear interaction. Cotransfection of N-terminal EYFP protein (EYFP(1)) fused to 
KLF11 with the C-terminal EYFP (EYFP(2)) fused to Gβ2 in both HeLa and Capan2 cells was performed 
and subsequently, cells were stimulated with isoproterenol or secretin, respectively. While control 
treatment (vehicle) does not show positive interaction, activation of GPCRs in both cell types (treatment) 
demonstrates interaction in the nucleus through fluorescence reconstitution and nuclear DAPI co-stain. E. 
GPCR stimulation translocates Gβ2 from the cell membrane to the nucleus where it co-localizes with 
KLF11. CHO-CCKAR cells were transiently transfected epitope-tagged Gβ2 and KLF11. Without 
stimulation of CCKAR (vehicle), Gβ2 localizes to the membrane and cytoplasm. Upon CCK treatment (+ 
CCK), Gβ2 (green) translocates to the nucleus where it localizes with KLF11 (red). Overlay shows 
extensive co-localization (yellow) of these two proteins, confirming their close proximity. 
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FIGURE 4. The KLF11 A347S MODY VII variant disrupts its ability to bind the Gβ subunit.   A. 
The KLF11-Gβ interaction in cells is altered by the A347S variant. Immunoprecipitation of His-tagged 
KLF11 wild type (WT) demonstrates binding with endogenous Gβ2 in Panc1 cells. However, 
immunoprecipitation of His-tagged KLF11 A347S shows that this variant disrupts its interaction with Gβ2. 
EV was used as a negative control. B. KLF11 A347S does not impair binding to other KLF11 co-factors. 
Although KLF11 A347S does not interact with Gβ2, immunoprecipitation of the His-tagged variant does 
not affect interaction with other known KLF11 co-factors, namely Sin3a, HP1gamma and CBP/p300. 
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FIGURE 5.  The KLF11 A347S MODY VII variant deregulates metabolic gene networks that 
require coupling of KLF11 to cofactors via the TRD3.  A.  Genome-wide query using a whole genome 
Affymetrix expression profile (ReGene 2.0) in pancreatic beta cells transduced with empty vector, KLF11, 
or the A347S variant.  Significant (p<0.05) genes were clustered to compare the effects of the A347S 
variant compared to wild type.  Detailed statistical and bioinformatics analysis identified unique genes that 
significantly associate with KLF11 expression (p<0.05, log2 fold change +/-2).  This analysis reveals that 
the targets significantly repressed or activated under wild type stimulation are de-repressed or de-activated 
in the presence of the A347S variant.  B.  Gene ontology ANOVA analysis of KLF11 and A347S targets 
reveals a distinct and enrichment of insulin secretion and response pathway ontological clusters that are 
significantly disrupted in the presence of the A347S variant.  C.  qPCR validation of a panel of insulin 
secretion and response genes again reveals the disruptive effect of the A347S variant identified by global 
expression profiling in Part A.  Asterisks equals gene targets where the A347S variant deregulation is 
significant compared to wild type (p<0.05).  
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FIGURE 6. Regulatory effect of Gβ2 overexpression on a subset of identified KLF11 target genes. A.  
Targets significantly regulated by KLF11 demonstrate similar activation or repression in the presence of 
Gβ2 overexpression with a 3X SV40 nuclear localization signal. Significance was assumed at p<0.05, log2 
fold change +/-1.5 for either KLF11 vs EV or Gβ2 vs EV. B.  Co-occupation of KLF11 and Gβ at human 
gene promoters.  ChIP was utilized to examine co-occupation of KLF11 and Gbeta on regions of human 
gene promoters up to 5kb upstream of the transcriptional start site in epithelial cells.  False discovery rate is 
presented here as error on reported peak scores. 
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Supplemental Figure 1: Comparative effects of KLF11, A347S, and G2 expression in human 
epithelial cells.  A.  Genome-wide query using a whole genome Affymetrix expression profile (Human 
Gene 1.0 ST) in exocrine epithelial cells transduced with empty vector, KLF11, or the A347S variant.  
Significant (p<0.05) genes were clustered to compare the effects of the A347S variant compared to wild 
type.  B.  Gene ontology ANOVA analysis of glucose metabolism and insulin response pathways reveals 
disruption by the A347S variant, a subset of which are presented here.   
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TABLE 1. List of potential KLF11 TRD3-interacting proteins identified by yeast two hybrid and 
protein array.  
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Supplementary Table 1:  Analysis of the entire subset of KLF proteins predicts the presence of the 
TRD3 in a large number of KLF proteins outside of the cabut subfamily.  Examination of 
hydrophobic-glycine-glutamine-proline enrichment across all members of the KLF family. Φ denotes 
hydrophobic residues. 
 
 
 
KLF1 (1-280aa) 
ΦΦTΦETΦΦPSΦSTΦTΦΦGPΦPDTQDDΦΦK
ΦΦRSEEΦQDΦGPGPPDPTEPPΦHΦKSEDQ
PGEEEDDERGΦDΦTΦDΦDΦΦΦTNΦSGPEP
GGΦPQTΦΦΦΦPSEΦSGΦQYPPPPETΦGΦY
ΦGGPGΦΦΦGΦΦGSEDHSGΦΦRPΦΦRΦR
ΦPDΦΦΦGPΦΦΦPΦPΦPEPKΦΦΦΦQPΦYP
GPGΦGSSGGYΦPRTGΦSΦPΦΦSGΦPYGΦ
ΦSGYPΦΦYPΦPQYQGHΦQΦΦRGΦQGPΦP
GPΦTSPSΦΦSΦΦGPGTΦGTGΦGGTΦEDPG
ΦΦΦETΦPSKRGRRSΦΦRKRQΦΦHT 
 
 
KLF2 (1-273aa) 
ΦΦΦSEPΦΦPSΦSTΦΦSPΦRERGΦQERΦP
RΦEPESGGTDDDΦNSΦΦDΦΦΦSΦGΦDGΦ
GΦEΦΦPEPPPPPPPPΦΦYYPEPGΦPPPYSΦ
PΦGGΦΦSEΦΦRPEΦDΦPΦGPΦΦHGRΦΦΦ
ΦPPGRΦΦKΦEPPEΦDGGGGYGΦΦPGΦTR
GPRGΦKREGΦPGPΦΦSΦΦRGPGGRPPPPP
DTPPΦSPDGPΦRΦPΦPGPRΦSΦPPPΦGGP
GΦGΦPGPGΦHYΦPPΦPPΦΦGΦΦDDΦΦΦΦ
ΦΦΦΦGΦΦPPΦΦRGΦΦTPPΦSPΦEΦΦEΦK
PKRGRRSΦPRKRTΦTHT 
 
 
KLF3 (1-261aa) 
ΦΦΦΦDPΦPΦKQEΦΦDPΦSΦSYPSNYΦES
ΦKPNKYGΦΦYSTPΦPEKΦΦQTPEGΦSHGΦ
QΦEPΦDΦTΦNKRSSPPSΦGNSPSSΦKΦPS
SHRRΦSPGΦSΦPSSSPPΦKKYSPPSPGΦQP
ΦGΦPΦSΦPPΦΦΦΦΦΦSRHGΦRSPGΦΦPΦ
ΦQPΦΦΦQPΦPΦΦYTSHΦQQPΦΦΦSΦSEE
ΦENSSSSΦQΦPΦΦESYEKPΦSQKKΦKΦEP
GΦEPQRTDYYPEEΦSPPΦΦNSΦSPPQΦΦΦ
QENHPSΦΦΦQPGKRPΦPΦESPDTQRKRRΦ
HR 
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KLF4 (1-397aa) 
ΦRQPPGESDΦΦΦSDΦΦΦPSΦSTΦΦSGPΦ
GREKTΦRQΦGΦPNNRΦREEΦSHΦKRΦPPΦ
ΦPGRPYDΦΦΦΦTΦΦTDΦESGGΦGΦΦΦGG
SNΦΦPΦPRRETEEΦNDΦΦDΦDΦΦΦSNSΦT
HPPESΦΦΦTΦSSSΦSΦSSSSSPSSSGPΦSΦ
PSTΦSΦTYPΦRΦGNDPGΦΦPGGTGGGΦΦY
GRESΦPPPTΦPΦNΦΦDΦNDΦSPSGGΦΦΦ
EΦΦRPEΦDPΦYΦPPQQPQPPGGGΦΦGKΦ
ΦΦKΦSΦSΦPGSEYGSPSΦΦSΦSKGSPDGS
HPΦΦΦΦPYNGGPPRTΦPKΦKQEΦΦSSΦTH
ΦGΦGPPΦSNGHRPΦΦHDΦPΦGRQΦPSRTT
PTΦGΦEEΦΦSSRDΦHPΦΦPΦPPGΦHPHPG
PNYPSΦΦPDQΦQPQΦPPΦHYQEΦΦPPGSΦ
ΦPEEPKPKRGRRSΦPRKRTΦTHT 
 
 
KLF5 (1-374aa) 
ΦΦTRΦΦSΦSΦRΦGPΦPQPPΦPQDEPΦΦΦ
QΦKPΦΦGΦΦNPΦRDΦΦΦΦPGEEΦKHΦHH
RPQΦQPΦPΦQΦPQPΦQPPΦTGPRΦPPEDΦ
ΦQTRΦEΦEKYΦTPQΦPPΦPΦΦPEHKKYRR
DSΦSΦΦDQΦΦTDTEGΦPYSΦNΦNΦΦΦPD
ΦTHΦRTGΦYKSQRPΦΦTHΦKTEPΦΦΦΦSH
QSETTΦPPPΦPTQΦΦPEΦTSΦΦSSHQTΦΦ
PEΦNNΦΦΦKQEΦPTPDΦHΦSΦPTQQGHΦY
QΦΦNTPDΦDΦPSSTNQTΦΦΦDTΦNΦSΦSΦ
ΦΦΦGΦNTHTSΦΦPQTΦΦKQΦQGΦPPΦTY
TΦPSQΦΦPQQΦTYΦPPSPPSSEPGSPDRQ
ΦEΦΦQNΦTPPPSYΦΦTΦΦSKΦΦΦHNPNΦ
PTTΦPΦNSQNΦQPΦRYNRRSNPDΦEKRRΦ
HY 
 
 
KLF6 (1-201aa) 
ΦDΦΦPΦΦSΦΦQEΦQΦΦHETGYΦSΦΦPSΦ
EEYΦQQTΦΦEΦERYΦQSEPΦYΦSΦSEΦKΦ
DSQEDΦΦTKΦΦΦΦREKKEESEΦKΦSSSPP
EDTΦΦSPSΦΦYNΦETNSΦNSDΦSSESSDSS
EEΦSPTΦKΦTSDPΦGEΦΦΦSSGKΦSSSΦT
STPPSSPEΦSREPSQΦΦGΦΦPGEΦPSPGK
ΦRSGTSGKPGDKGNGDΦSPDGRRRΦHR 
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KLF7 (1-220aa) 
ΦDΦΦΦSYSΦΦQEΦQΦΦHDTGYΦSΦΦPSΦ
EETΦQQTΦΦEΦERYΦQTEPRRΦSETΦGED
ΦDΦΦΦHΦSPPPΦΦEESΦRRΦDPΦΦΦPΦE
ΦΦΦΦEKSSΦΦDΦΦΦSRDKΦΦSETΦΦSΦQ
PΦSSSΦDSYTΦΦNQΦQΦNΦΦTSΦTPPSSP
EΦSRHΦΦKTSQTΦSΦΦDGTΦTΦKΦΦΦKK
ΦΦΦSSΦKΦGGΦΦTΦΦΦΦΦTΦΦGΦΦKSG
QSDSDQGGΦGΦEΦΦPENKKRΦHR 
 
 
KLF8  (1-275aa) 
ΦΦDΦDKΦΦNNΦEΦQΦNSEGGSΦQΦΦKQ
ΦTΦSΦRNRDPPEΦEYRSNΦTSPTΦΦDΦNP
ΦENPΦΦΦNDΦKΦEPPEEΦΦΦSDΦSΦPQΦ
EPΦDΦSΦHKPKΦPΦQPΦSΦΦQΦPΦRPPK
PQSSPQTΦΦΦSTSTSDΦSTSΦNΦPTΦΦTPG
SΦΦTSSQSTGSQQΦΦHΦΦHTΦPSΦSΦPNK
ΦGGΦKTΦPΦΦΦQSΦPΦΦYTTΦPΦDGGPΦ
ΦΦTΦPΦΦGGDGKNΦGSΦKΦDPTSΦSPΦE
ΦPSDSEESTΦESGSSΦΦQSΦQGΦQQEPΦΦ
ΦΦQΦQGEESΦDΦKRRRΦHQ 
 
 
KLF12 (1-318aaa) 
ΦNΦHΦKRKTΦKNΦNTΦENRΦΦΦΦDGΦPΦ
ΦRΦKTEΦΦESEQGSPNΦHNYPDΦEΦΦPΦΦ
ΦNNΦKGEPPEDSΦSΦDHΦQTQTEPΦDΦSΦ
NKΦRTSPTΦΦSSSPΦSΦTΦSΦSSPSSTSTS
SSSSSRΦΦSSPTΦΦTSΦSSΦSSSSTΦΦTPG
PΦΦΦSΦSGΦGGQQΦΦHΦΦHPΦPPSSPΦN
ΦQSNKΦSHΦHRΦPΦΦΦQSΦPΦΦYTΦΦRS
PGNΦNNTΦΦΦPΦΦEDGRGHGKΦQΦDPRG
ΦSPRQSKSDSDDDDΦPNΦTΦDSΦNETGST
ΦΦSΦΦRΦΦQEΦHPSPΦSRΦRGNRΦNNQK
ΦPΦSΦSPΦSΦESTRRQRRSESPDSRKRRΦ
HR 
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KLF15 (1-322aa) 
ΦΦDHΦΦPΦDENΦSSPKΦPΦGYΦGDRΦΦG
RRΦYHΦΦPSPΦSEDDSDΦSSPΦSΦSSPDS
QΦΦΦSΦYGGGΦGTESQDSΦΦDΦΦΦSQΦT
ΦGSGGGSGSSΦGΦSSGPΦΦΦGPΦRRΦΦΦ
PΦKGEHΦΦΦPEΦPΦGDPDDΦPRPΦQPTΦE
EΦEEΦΦEENΦEPGΦKEΦPEGNSKDΦDΦΦS
QΦSΦGPHKSHΦHPGSSGRERΦSPPPGGΦS
ΦGGΦQGPGGGPTPDGPΦPΦΦΦQΦQPΦPΦ
KQESGTGPΦSPGQΦPENΦKΦΦQΦΦΦNΦQ
GQTΦΦΦΦPQΦΦPSSNΦNΦPSKΦΦRΦΦPΦ
PΦΦΦKPΦGSGPΦGPGPΦGΦΦΦGQKΦPKN
PΦΦEΦΦKΦHK 
 
 
KLF17 (1-284aa) 
ΦYGRPQΦEΦEQEΦGEΦSRΦQΦΦHQΦΦQD
NENSΦPΦΦNΦSSSSGSSGΦHTSΦNQGΦPS
ΦQHΦPHSΦEΦΦGSPΦΦSΦEΦPGQNΦNEG
GPQΦSΦPΦPERGΦSYΦPQΦTΦTPSRΦΦYΦ
QRΦSPPQQEΦTΦΦSGPQΦΦPΦGEPNΦPR
ΦΦRPΦGGNΦRΦPPNGΦPΦSΦSTGΦPΦΦS
HTGNPPΦPYPGΦSTΦPSDETΦΦGPTΦPSTE
ΦQΦΦΦPSΦΦQΦΦPPQDΦHDΦGΦPPΦESQ
SΦΦΦΦGSQDSΦΦSQPDSQEGPΦΦPEQPG
PΦPQTΦEKNSRPQEGTGRRGSSEΦRPYΦ 
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Supplementary Table 2: KLF11 overexpression regulates the insulin response pathway. Affymetrix 
gene expression data were examined for significant enrichment of genes clustered into a range of insulin 
response biological, molecular, and cellular functions using the Partek GO ANOVA function.  The effects 
of the A347S variant are also examined as well as the significance of the disruption between the wild type 
to the variant. The top 100 results are included here. 
 
 
GO Description p-value(KLF11 
vs. EV) 
Fold-
Change(KLF11 
vs. EV) 
p-value(V347 vs. 
EV) 
Fold-
Change(V347 vs. 
EV) 
mesenchymal cell 
development 
5.01E-10 -1.39052 7.46E-09 -1.26432 
G1/S transition of mitotic 
cell cycle 
1.28E-09 -1.20204 6.01E-09 -1.16354 
dendrite development 1.53E-09 -1.29662 1.19E-08 -1.22204 
embryonic 
morphogenesis 
7.24E-09 -1.32189 2.16E-08 -1.27511 
protein K48-linked 
deubiquitination 
8.21E-09 -1.40555 2.44E-08 -1.34517 
rRNA transcription 1.05E-08 1.52551 3.84E-08 1.4308 
L-glutamate transport 1.14E-08 1.43933 3.71E-09 1.52134 
regulation of protein 
localization 
1.55E-08 -1.21315 1.50E-07 -1.15567 
intracellular protein 
kinase cascade 
1.95E-08 -1.26037 2.25E-07 -1.18449 
protein deubiquitination 2.19E-08 -1.46812 7.02E-08 -1.39243 
spindle organization 2.39E-08 -1.42709 3.62E-08 -1.40124 
response to aluminum ion 2.71E-08 -1.35497 5.41E-07 -1.23004 
SCF-dependent 
proteasomal ubiquitin-
dependent protein 
catabolic process 
2.72E-08 -1.32973 2.29E-07 -1.24247 
positive regulation of 
microtubule 
polymerization 
3.34E-08 -1.44954 3.26E-07 -1.31973 
renal system process 3.54E-08 -1.4023 1.55E-07 -1.32336 
oxaloacetate metabolic 
process 
3.59E-08 -1.37133 4.43E-06 -1.18461 
ear development 3.62E-08 -1.49717 3.14E-07 -1.35814 
response to external 
stimulus 
3.89E-08 -1.44702 1.57E-07 -1.36236 
positive regulation of 
insulin secretion involved 
in cellular response to 
glucose stimulus 
3.89E-08 -1.24569 6.41E-08 -1.22893 
regulation of cell-matrix 
adhesion 
4.14E-08 -1.44108 2.22E-07 -1.34292 
homocysteine metabolic 
process 
4.31E-08 -1.31413 1.85E-06 -1.18332 
endoplasmic reticulum 
calcium ion homeostasis 
4.61E-08 -1.38695 3.04E-07 -1.293 
  52 
striated muscle cell 
differentiation 
4.72E-08 -1.33691 3.31E-07 -1.25389 
regulation of circadian 
rhythm 
4.73E-08 -1.3389 6.47E-07 -1.23201 
calcium ion-dependent 
exocytosis 
4.91E-08 -1.50221 9.29E-07 -1.32168 
nerve growth factor 
receptor signaling 
pathway 
5.35E-08 -1.39293 5.78E-07 -1.27657 
regulation of smoothened 
signaling pathway 
5.40E-08 1.26274 1.15E-07 1.23592 
positive regulation of 
protein serine/threonine 
kinase activity 
5.63E-08 -1.40625 4.72E-07 -1.29638 
protein localization to 
synapse 
6.14E-08 -1.33427 5.09E-07 -1.24588 
lipid biosynthetic process 6.55E-08 -1.53319 4.42E-07 -1.39724 
regulation of viral 
genome replication 
7.24E-08 -1.32982 3.21E-07 -1.26552 
protein 
dephosphorylation 
7.60E-08 -1.21527 1.37E-06 -1.14368 
mitotic spindle 
organization 
8.65E-08 -1.28237 4.43E-07 -1.22348 
inositol phosphate 
dephosphorylation 
9.54E-08 -1.14343 3.14E-07 -1.12194 
response to inorganic 
substance 
1.00E-07 -1.14719 6.71E-06 -1.08273 
cellular response to 
glucose starvation 
1.04E-07 -1.25547 4.27E-06 -1.15076 
negative regulation of 
neuron death 
1.04E-07 -1.13357 2.17E-06 -1.08836 
fatty acid beta-oxidation 1.12E-07 -1.12029 5.91E-06 -1.07016 
B cell proliferation 1.13E-07 -1.23073 9.01E-07 -1.17225 
positive regulation of 
protein ubiquitination 
involved in ubiquitin-
dependent protein 
catabolic process 
1.18E-07 -1.11053 6.05E-08 -1.12089 
positive regulation of 
exocytosis 
1.21E-07 -1.40459 2.39E-06 -1.25974 
positive regulation of 
nitric-oxide synthase 
biosynthetic process 
1.24E-07 -1.36115 9.06E-07 -1.26957 
autophagic vacuole 
assembly 
1.24E-07 1.24965 8.09E-07 1.19137 
regulation of exocytosis 1.46E-07 -1.52926 1.67E-06 -1.36335 
positive regulation of 
insulin secretion 
1.48E-07 -1.29859 1.16E-06 -1.22196 
mRNA polyadenylation 1.49E-07 1.49056 1.73E-06 1.33739 
response to folic acid 1.53E-07 -1.20648 3.60E-07 -1.18313 
regulation of 
developmental 
1.55E-07 -1.33828 5.09E-07 -1.28414 
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pigmentation 
decidualization 1.56E-07 1.18291 2.73E-07 1.16919 
response to hydrogen 
peroxide 
1.58E-07 -1.12074 8.50E-06 -1.07007 
regulation of cell 
morphogenesis 
1.63E-07 -1.3678 9.23E-07 -1.28469 
phosphorylation 1.68E-07 -1.20536 4.23E-06 -1.13061 
circadian regulation of 
gene expression 
1.70E-07 -1.39288 2.67E-06 -1.26096 
T cell homeostasis 1.79E-07 -1.22832 1.65E-06 -1.1668 
myoblast fusion 1.79E-07 -1.43636 1.54E-06 -1.3153 
peptidyl-threonine 
phosphorylation 
1.84E-07 -1.26313 7.73E-07 -1.21421 
positive regulation of 
protein ubiquitination 
1.97E-07 -1.14452 1.30E-06 -1.11154 
regulation of alternative 
mRNA splicing, via 
spliceosome 
2.10E-07 -1.11256 2.53E-07 -1.10971 
intrinsic apoptotic 
signaling pathway in 
response to oxidative 
stress 
2.22E-07 -1.2897 2.86E-06 -1.20024 
neuron-neuron synaptic 
transmission 
2.24E-07 -1.18996 1.40E-06 -1.14705 
V(D)J recombination 2.26E-07 -1.22659 4.77E-07 -1.20379 
oocyte development 2.34E-07 -1.61139 1.14E-06 -1.47473 
glycogen biosynthetic 
process 
2.34E-07 -1.34121 4.62E-06 -1.22021 
positive regulation of 
DNA repair 
2.39E-07 1.14253 1.42E-06 1.11156 
histone H4-K5 
acetylation 
2.42E-07 -1.1583 1.04E-07 -1.17786 
histone H4-K8 
acetylation 
2.42E-07 -1.1583 1.04E-07 -1.17786 
regulation of protein 
stability 
2.50E-07 -1.15563 2.58E-07 -1.15496 
antigen processing and 
presentation of 
exogenous peptide 
antigen via MHC class II 
2.51E-07 1.24185 5.36E-06 1.15638 
fatty acid metabolic 
process 
2.60E-07 -1.16833 1.76E-05 -1.09347 
B cell lineage 
commitment 
2.69E-07 -1.32839 8.32E-07 -1.27809 
growth 2.77E-07 -1.16397 1.10E-05 -1.09826 
positive regulation of 
erythrocyte 
differentiation 
2.87E-07 -1.26914 6.29E-06 -1.17264 
positive regulation of 
interleukin-8 production 
2.90E-07 1.2234 8.83E-07 1.19078 
cell projection 3.04E-07 1.15778 0.000447915 1.05562 
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organization 
regulation of I-kappaB 
kinase/NF-kappaB 
cascade 
3.06E-07 1.19668 1.78E-06 1.1536 
regulation of apoptotic 
process 
3.10E-07 -1.10279 3.36E-06 -1.07439 
glucose metabolic 
process 
3.18E-07 -1.25251 1.98E-06 -1.19421 
negative regulation of 
ossification 
3.49E-07 -1.21558 1.17E-05 -1.1309 
oocyte maturation 3.99E-07 -1.3428 5.51E-06 -1.23259 
dopamine metabolic 
process 
3.99E-07 -1.30377 1.27E-05 -1.18324 
epidermal growth factor 
receptor signaling 
pathway 
4.03E-07 -1.14529 2.30E-05 -1.08273 
positive regulation of 
peptidyl-serine 
phosphorylation 
4.09E-07 -1.20445 1.93E-06 -1.16424 
oxidative 
phosphorylation 
4.36E-07 -1.33135 3.98E-06 -1.23913 
dopamine receptor 
signaling pathway 
4.79E-07 -1.3151 2.62E-06 -1.24546 
positive regulation of 
GTPase activity 
4.84E-07 -1.25783 4.18E-06 -1.18895 
regulation of ARF 
GTPase activity 
4.84E-07 -1.3397 5.01E-06 -1.24035 
positive regulation of 
neuroblast proliferation 
4.91E-07 -1.23322 5.73E-06 -1.16412 
filopodium assembly 4.92E-07 -1.34275 3.79E-06 -1.25323 
negative regulation of 
peptidyl-serine 
phosphorylation 
5.11E-07 1.42863 2.75E-05 1.23402 
response to virus 5.19E-07 1.07692 1.24E-06 1.06839 
regulation of protein 
kinase A signaling 
cascade 
5.36E-07 -1.23193 4.13E-06 -1.17316 
response to sucrose 
stimulus 
5.57E-07 1.25002 5.85E-06 1.17815 
cellular respiration 5.59E-07 1.42991 1.84E-05 1.25273 
response to organic 
nitrogen 
5.73E-07 -1.09883 0.000133857 -1.0462 
negative regulation of 
protein complex 
assembly 
5.76E-07 -1.27837 6.61E-06 -1.1952 
chromatin modification 5.99E-07 -1.07438 5.10E-07 -1.076 
axonogenesis 6.02E-07 -1.21985 4.69E-06 -1.16403 
Golgi organization 6.23E-07 -1.13535 1.35E-06 -1.12161 
cholesterol biosynthetic 
process 
6.26E-07 -1.73814 2.52E-05 -1.40319 
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SUMMARY 
Krüppel-like factors (KLFs) are a group of master regulators of gene expression 
conserved from flies to human.  However, scant information is available on either the 
mechanisms or functional impact of the coupling of KLF proteins to chromatin 
remodeling machines, a deterministic step in transcriptional regulation.  In the current 
study, we have used genome-wide analyses of chromatin immunoprecipitation (ChIP-on-
Chip) and Affymetrix-based expression profiling to gain insight into how the KLF11, a 
human transcription factor involved in tumor suppression and metabolic diseases, works 
by coupling to three co-factor groups: the Sin3-histone deacetylase system, WD40-
domain containing proteins, and HP1-histone methyltransferase system.  Our results 
reveal that KLF11 regulates distinct gene networks involved in metabolism and growth 
by using single or combinatorial coupling events.  This study, the first of its type for any 
KLF protein, reveals that interactions with multiple chromatin systems are required for 
the full gene regulatory function of these proteins. 
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INTRODUCTION 
The traditional strategy for studying the role of transcription factors in gene regulation 
relies on either small or large-scale expression analysis following overexpression, 
somatic knockdown, or germ line deletion.  While these approaches permit the 
identification of gene networks regulated by transcription factors, little information is 
gathered about the chromatin coupling events that ultimately drive gene expression.  This 
gap in knowledge is unfortunate as transcription factors are often modular proteins armed 
with multiple sites for potential interactions with chromatin cofactors.  Thus, knocking 
out a transcription factor will, in theory, disrupt all chromatin-coupling events. For this 
reason, it is important to dissect whether define transcriptional regulators use single or 
combinatorial coupling events to regulate different gene expression networks.   
 
Such knowledge is particularly important for proteins in which dysfunction contributes to 
disease since impairment in each of the coupling events can have potentially differential 
impact, serving as a cause of variation in symptoms as well as progression. Moreover, 
with the development of novel chromatin-centric pharmacology, different drugs can 
partially inactivate certain gene networks regulated by a transcription factor while leaving 
others intact.  Therefore, dissecting individual and combinatorial chromatin coupling 
events has both biological and medical relevance.  
 
Consequently, the current study focuses on studying KLF11 as a model system for 
addressing these important questions.  KLF11 is a well characterized human disease 
causing gene, which couples to several chromatin partners (156). Alterations in KLF11, 
originally discovered by its role in growth regulation, causes juvenile (MODY7) and 
neonatal diabetes (Ins-331 mutation) diabetes (118,157,158). KLF11 is an inducible gene, 
responsive to a large variety of growth regulatory and metabolic stimuli, and functions in 
the nucleus to regulate gene expression by coupling to distinct chromatin partners. Upon 
stimuli, KLF11 binds to promoters containing the consensus CCCCGC/CCCCAC 
  58 
sequences via its three C-terminal zinc finger domains and, through well-characterized 
protein-protein interaction modules in its N-terminus, differentially recruits chromatin 
partners such as the Sin3-HDAC complex (159), WD40 proteins (160), and the HP1-
HMT system (161). Thus, through the use of these domains, KLF11 can translate 
environmental signals into distinct programs of gene expressions, which remain being 
defined in detail.   
 
In the current study, we have employed a combination of genome-wide ChIP-on-Chip 
and expression profiles, to reconstruct both direct and indirect effects of KLF11 on the 
regulation of different gene networks.  Furthermore, we used specific site-directed 
mutants known to disrupt specifically each of the chromatin coupling domains to 
generate expression profiles as a genome-wide reporter for the identification of the subset 
of genes regulated by KLF11 in response to binding to each of its chromatin cofactors.  
The results of these experiments demonstrate that a single chromatin machine can either 
regulate KLF11-regulated genes while others require interactions with more than one 
system.  Accordingly, we provide analyses of the distinct gene networks regulated by this 
transcription factor and its partners. This type of comprehensive genome-wide analysis 
has never been performed for any member of the KLF family and, when applied to 
KLF11, demonstrates that these proteins behaves a modular with the ability of using 
single chromatin proteins or a combination of them to achieve their gene regulatory 
function. 
 
RESULTS 
Distinct gene expression networks are regulated by the differential coupling of KLF11 to 
individual chromatin partners. 
Recent studies support a model whereby KLF11 functions by binding to GC-rich sites 
within promoters of different gene networks involved in the regulation of metabolism and 
cell growth (118,157,158,161-166).  This data is in agreement with the biological role of 
this transcription factors in cancer and diabetes.  However, how binding of KLF11 to 
these promoters regulates gene expression remains to be fully understood.  Recent data 
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demonstrate that the KLF11 protein behaves as a scaffold for recruiting different 
chromatin cofactors via distinct structural motifs (Figure 1A).  The Sin3 Interacting 
Domain (SID) between amino acids 22-40 enables coupling of KLF11 to the Sin3/HDAC 
system (91,165-172). Introduction of proline residues at amino acids 29-30 interrupts the 
association between KLF11 and the Sin3 scaffold protein, which includes interactions 
with HDAC1/2.  The region between 281 and 373 amino acids is a proline-rich domain 
that couples with a variety of WD40 proteins, including G-protein coupled receptors 
(173).  The A347S mutation observed in MODY7 (neonatal diabetes) falls within this 
domain and has been demonstrated to decouple KLF11 from novel transcription factor 
G2.  The zinc finger domain has been demonstrated to interact with histone 
acetyltransferases p300 and CBP (158,174,175).  Finally, the region between 483 and 487 
dictates interaction between KLF11 and HP1 (161).  Deletion of this C-terminal portion 
decouples HP1 from histone methyltransferases SUV39 and G9a, leading to defects in 
metabolism and tumor suppression.  Currently, it is unknown whether these systems work 
in isolation or in a cooperative manner to regulate gene expression.  
 
To address this question, we first preformed genome-wide promoter binding analysis of 
wild type KLF11.   404 identifiable gene promoters were bound by KLF11.  Gene 
ontological analysis of these targets reveals association to a large number of metabolism 
processes, including many already characterized as regulated by KLF11, including 
insulin regulation (118,158,166) and Akt/TOR signaling (165) (Figure 1B).  Next, we 
performed genome-wide expression profiles using specific mutants for these sites which 
have been shown to specifically uncouple KLF11 from each of these chromatin 
remodeling proteins, namely EAPP (Sin3/HDAC), A347S (WD40 proteins), and 486 
(HP1/HMT).   Of the 404 gene targets identified by chromatin immunoprecipitation, 
19% (n=75) display alteration in the presence of the wild type KLF11 (p<0.05). 
Clustering analysis reveals that the expression pattern of these gene targets is disrupted in 
the presence of one or all of the described mutants.  Thus, we conclude that KLF11 
mediated gene expression may be disrupted by decoupling of the transcription factor 
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from its chromatin co-factors in a combinatorial or singular fashion. 
 
Distinct gene networks are regulated by the combinatorial coupling of KLF11 to 
chromatin partners. 
Next, we investigated which gene targets are uniquely regulated by each of these 
pathways. Statistical analyses of each expression profiles show that, indeed, when 
compared with the empty vector control condition, each mutation induces changes in 
gene expression which are either specific to each chromatin system or similar to the wild 
type. Thus, comparison of the genes significantly affected by each condition (p-value 
<0.05 and fold change ± 1.5) shows that 97% of transcripts that are modulated by the 
wild type KLF11 are also regulated by any of the three mutations, with the A347S and 
486 mutations sharing the largest number of genes with the wild type (Figure 2A).  In 
fact, of the 801 genes modulated by the 486 mutation, 93.9% are also modulated by the 
A347S mutation. Finally, the three mutants share with KLF11 only 11 different genes, 
which likely require an intact coupling of this transcription factor to all the chromatin 
proteins involved in its function (Figure 2B).  We observe that the A347S mutation 
shows the largest number of significantly regulated transcripts (n=708) upon the 
decoupling of KLF11 from WD40 proteins (Figure 3A). By contrast, the subsets of genes 
uniquely regulated by the 486 or EAPP mutants are much smaller, 44 and 21 genes, 
respectively (Figures 3B-C).  
 
The 486 mutation uniquely modulates only 44 genes (5.5%) of the 801 genes 
significantly modulated under expression of the mutant.  Almost a half of all 486 
modulated genes (n=390) are common to the A347S mutant (Figure 3D) and the other 
half are common to both A347S and wild type KLF11 (Figure 3E).  Interestingly, the 
486 and the A347S mutants have, in general, a similar direction of modulation, although 
with varying degrees of signal intensity. On the other hand, the A347S and 486 
modulated genes are almost always completely reverted by the EAPP mutation, in which 
the signals are constantly proximal to empty vectors values. 
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Under the same conditions, the A347S mutant, which associates to the development of 
human juvenile diabetes, induces changes in 1521 genes.  46.5 % of the modulated genes 
(708/1521) are specific to this mutation, while approximately half of the genes (48%) are 
common to the 486 mutant and 43.3% are common to both A347S and wild type 
KLF11 (352/423, Figure 3F). Finally, 7% of the genes (n=50) are common to wild type 
KLF11, and only 15 common to the EAPP mutant. The EAPP mutation, which disrupts 
coupling to the Sin3-HDAC complex, reverses the expression of most genes induced by 
the wild type KLF11 or by the other two mutations. 
  
Identification of KLF11-regulated genes for which expression is independent of known 
chromatin coupling events. 
Subsequently, we examined genes for which expression might be regulated by KLF11 in 
a manner that does not involved the chromatin remodeling machines examined above.  A 
small percentage of genes are still significantly modulated uniquely by wild type KLF11 
(Figure 3G).  Ontological classification demonstrate that these 14 genes are associated 
with diabetes (ALMS1P; RAET1L; GYS1; RBM47; EFR3B), cancer (RPL27A; SPAM1; 
PTCH1; ZNF277; USP35; CDC86), or metabolism (C3orf15; AOC2; GOT1).  Taken 
together, these data indicate that the vast majority of KLF11’s biological processes are 
dependent on its interaction with chromatin regulators although a repertoire of chromatin-
independent functions is expected. 
 
Pathway reconstruction of combinatorial KLF11-regulated chromatin pathways by 
ontological approach. 
Gene Ontology (GO) enrichment analysis of the genes modulated by wild type KLF11 
and each of the three mutations show various common biological processes (Figure 4A). 
Indeed, the wild type shares 60% (34/57) of the biological process with at least one of the 
mutants.  One of the biological processes, lipid cellular metabolic process, is enriched in 
wild type KLF11 and all three mutants (Supplemental Table 1). Among the most highly 
enriched biological processes, 14 terms are common to wild type and the A347S and 
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486 mutations. Variations of the intensity of signal, the number of genes implicated, and 
the score of GO enrichment for these 14 biological processes are shown in Supplemental 
Table 1. Interestingly, wild type KLF11 and mutants conserve several biological 
processes related to anabolism or catabolism of lipids, amino acids, and glycoconjugates. 
Other common groups include redox processes of protein homodimerization, regulation 
of the activity of protein kinases, and response to the estrogen. 
 
Two of the wild type KLF11 biological processes, the G2/M transition during DNA 
damage checkpoint and cilium assembly are also conserved in the A347S mutation. 
There are 16 biological processes exclusively conserved between wild type KLF11 and 
the 486 mutant. These include cellular metabolic processes such as aldehyde and 
nitrogen compound metabolism, isocitrate and 2-oxoglutarate metabolism, 
glycosaminoglycan catabolic processes, and fatty acid beta-oxidation.  
 
Interestingly, the A347S and 486 mutation share more than a quarter of biological 
processes (n=39) that are absent in wild type KLF11 and the EAPP mutant. Between 
these 39 GO terms, we found enrichment of terms associated to the monitoring of the 
DNA transcription, RNA polymerase I transcription promoter regulation, and epigenetic 
control of gene expression such as histone H3 acetylation, chromatin remodeling, protein 
acetylation and deacetylation, and regulation of phosphorylation.  Wild type KLF11 and 
EAPP share only two GO-terms in common: branched chain amino acid family catabolic 
processes and negative regulation of TOR and signaling cascade.   
 
Overall, 22 of 57 (38.6%) of the biological processes enriched in the wild type KLF11 
are not present any of the three mutants. Among the 22 most enriched biological process 
found only in the wild type KLF11, we observed several metabolic processes, such as 
glucose, carbohydrate, and very long-chain fatty acid metabolism, oxaloacetate 
metabolism, fatty acid homeostasis, and oligosaccharide metabolism. Top processes 
associated with wild type KLF11 expression are shown in Figure 4B and Supplemental 
Table 2.  Other specific mechanisms of wild type KLF11 lost by mutation are two 
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mechanisms associated with gene expression (transcription from the RNA polymerase III 
promoter and mRNA capping) and two biological processes associated with the integrity 
of the DNA (the DNA repair and the response to DNA damage stimulus). Finally three 
important biological processes (e.g., the mitotic cell cycle, the negative regulation of 
insulin-like growth factor receptor signaling pathway, and the negative regulation of 
epithelial cell proliferation) are also lost by the mutants. From these data we conclude 
that the majority of KLF11’s function, particularly in regulating gene expression and 
metabolism, are dictated by the combinatorial association between the transcription factor 
and a variety of chromatin coupling systems.  The high degree in over suggests a form of 
“epigenetic redundancy” to ensure the proper regulation of these gene targets and 
processes. 
 
Pathway reconstruction of singular KLF11-regulated chromatin pathways by ontological 
approach. 
Of the mutants, A347S displays the highest number of unique biological process that are 
not enriched in the wild type (n=93). Top processes associated with A347S mutant 
expression are shown in Figure 4C and Supplemental Table 2.  Interestingly, almost 30% 
of these biological processes are associated with the structure and maintenance of DNA 
or telomeres (Supplemental Table 3, List 1), processes related to phosphorylation and 
dephosphorylation, deacetylation, methylation, and demethylation (Supplemental Table 
3, List 2), and processes of transcriptional regulation by poly-II and mRNA transport 
(Supplemental Table 3, List 3). 
 
In turn, the 486 mutant exclusively enriches 45 biological processes that are mediated 
by the wild type KLF11 or in other mutants.  Top processes associated with 486 
expression are shown in Figure 4C and Supplemental Table 2.  Unlike the A347S mutant, 
mutation 486 is particularly enriched in processes associated with metabolic and 
biosynthetic processes, protein export-import, process and energy protein modifications 
associated processes (Supplemental Table 4, List 1).  Other groups of processes 
specifically enriched in this mutant are associated with proliferation and epithelial cell 
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survival (Supplemental Table 4, List 2).   
 
The EAPP mutant did not display robust gene expression changes within the experiment.  
However, utilizing a more permissive cutoff yields a list of 53 biological categories, 
although each only contains a single gene. We find enrichment of biological processes 
involving nitric oxide transport, catabolic processes, developmental morphogenesis 
functions, among others.  Top processes associated with EAPP expression are shown in 
Figure 4E and Supplemental Table 2.  From these data, we are able to identify singular 
KLF11 chromatin coupling events dictating a number of critical processes, particularly in 
management of cell cycle control and DNA replication, ones that inherently require a 
more specific and more finely regulated degree of control to execute their programs 
under strict spatial and temporal constraints. 
 
Identification of canonical signaling pathways mediated by KLF11 and mutants. 
Subsequently, we wished to further assess the relatedness the gene targets significantly 
modulated by KLF11 and its mutants utilizing a semantic-based approach and the 
Ingenuity Global Canonical Pathways (GPC) algorithm.  The input dataset of 
significantly regulated gene targets was compared against the IPA canonical pathways, 
which are curated from published literature. The significance of the associations between 
the data set and a given canonical pathway is determined by the ratio of the number of 
genes mapping to the pathway divided by the total number of pathway genes.  A p-value 
is calculated using Fischer's Exact Test determining the probability that the association 
between the data set and the pathway occurs by chance alone.    GPC analysis of genes 
modulated by the wild type KLF11 and the three mutants shows a variety of significantly 
enriched pathways (p-value <0.05).  Indeed, the wild type KLF11 shares about 71% 
(30/42) of its pathways with at least one of the mutants (Figure 5A). The most important 
intersection of common pathways is observed between wild type KLF11 and mutants 
A347S and 486.  Indeed, 90% (38/42) of these pathways are also enriched in at least 
one of these two mutants.  Only two pathways are shared between the wild and the EAPP 
mutant. 
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Nevertheless, all genes implicated in these pathways are modulated differently by wild 
type KLF11 and each one of the mutants.  The expression of these genes significantly 
regulated by wild type KLF11 and the A347S and 486 mutants are almost always 
modulated in the same sense and clustered together (Figure 5B). In contrast, the deletion 
of the EAPP site produces a complete reversion of the signals, and the levels of 
expression of EAPP’s genes became close to the empty vector level, as evidence by its 
clustering with empty vector apart from the wild type KLF11 and other mutants. 
 
Twelve of the 42 significantly enriched pathways are conserved only in the wild type 
KLF11.  These normal functions of the wild type KLF11 are potentially lost by the three 
studied mutations.  The most enriched of these pathways includes the nucleotide excision 
repair pathway and the alpha-adrenergic signaling pathways.  Interestingly, of all the 
remaining pathways, 80% (9/11) of them are metabolic biosynthetic pathways.   
 
Mutant A347S possesses the most exclusive pathways.  Indeed, 28 pathways are enriched 
in the A347S mutant compared to wild type KLF11 and other mutants (Figure 5C). 
Interestingly, over 30% (9/28) of these pathways are signaling pathways, including, EGF, 
PDGR, p53, RANK and reelin signaling, and glucocorticoid receptor signaling.  
Furthermore, pathways involved in diabetes and pancreatic adenocarcinoma are also 
present. These pathways may explain the massive number of genes differentially 
modulated by this mutation (n=1521 genes) and suggests that this mutant could induce 
new potential unexpected and significant physiopathological changes.  
 
86% of the enriched pathways in the 486 mutant are shared with the wild type KLF11 
or the other mutants. Only four new pathways are specifically enriched by the 486 
mutation (Figure 5D). Interestingly, the pathways are implicated in the degradation of 
biogenic amines (an important field associated to physiopathology of depression and 
metabolism of drug of abuse).  Finally, the EAPP mutant influences only six pathways 
exclusively (Figure 5E), also primarily related to the degradation of biogenic amines.  
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Taken together, we conclude that KLF11 chromatin-coupled gene targets delineate into 
specific, well ordered pathways, consistent with KLF11’s position as a master 
transcriptional regulator that mediates large cascades of other transcription factors and 
regulators.  The effects of KLF11 chromatin coupling are therefore not incidental to its 
function but a primary means by which to execute gene activation or repression.  
 
Reconstruction of downstream biological and disease networks mediated by KLF11 and 
mutants. 
We next explored the degree of connectivity between KLF11 and mutant regulated genes 
and their pathobiological associations.  Networks of significantly regulated genes were 
algorithmically generated based on their connectivity and assigned a score that 
encapsulates the relevance of the generated network is to the original list of focus genes.  
All edges are supported by at least one literature reference of direct physical, 
transcriptional and enzymatic interactions or from canonical information stored in the 
Ingenuity Pathways Knowledge Base.  A right-tailed Fisher’s Exact Test was used to 
calculate the p-value for networks and a threshold of p<0.05 used to determine 
significance.  A functional analysis of a network then determined the biological functions 
and/or diseases that are most significant to the genes contained within the network 
(Figure 6). 
 
Of the identified processes, only three were common to wild type KLF11 and all three 
mutants: cell death and survival, hereditary disorders, and molecular transport 
mechanisms.  Wild type KLF11 possessed the most unique networks (n=10) and included 
a number of characterized biological and disease networks, including cellular growth and 
proliferation (176), endocrine disorders, reproductive system development and function 
(177), and biliary hyperplasia, among others.  The A347S mutant uniquely associates to 6 
networks, including ones linked to auditory disease, cellular compromise, and organismal 
development.  The 486 mutant uniquely associated to 8 networks.  Among the 486 
mediated networks are significant associations to gastrointestinal disease, connective 
tissue development, and immune presentation and response.  Together, these data 
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recapitulate the repertoire of known KLF11-mediated functions and uncover a number of 
new potential functional and disease associates for future studies.   
 
Identification of upstream regulators of KLF11-chromatin coupled pathways. 
Finally, we wished to identify the upstream transcriptional regulators using Ingenuity’s 
Upstream Regulator (UR) analysis.  The UR analytic is based on prior knowledge of the 
expected effects of transcriptional regulators and their target genes stored in the Ingenuity 
Public Knowledge Base.  The algorithm examines how many known targets of each 
transcriptional regulator are present in the list of significantly regulated targets and 
compares direction of expression to that expected from previously published data.  For 
each potential regulator, an overlap p-value using Fisher’s Exact Test and an activation z-
score was computed, the latter of which determines the activation state.  A threshold p-
value of <0.01 and activation score of +/- 2 was considered significant for our purposes.  
The end result was the identification of upstream regulators of KLF11 or its mutants that 
permits the generation of plausible signaling cascades mediated by these upstream 
regulators through KLF11 chromatin coupling. 
 
The results of the UR analysis are presented in Supplemental Table 5.  Wild type KLF11 
displayed two significant upstream inhibitory regulators, PPARG and HNF1A, both of 
which have previously been implicated in the regulation of the transcription factor or as a 
co-regulator (Figure 7A) (178).  The A347S mutant, consistent with the gene level, 
pathway, and network analyses is the most disruptive, possessing 9 activating upstream 
regulators and 23 inhibitory upstream regulators.  Interestingly, EZH2, a histone 
methyltransferases, is identified as potential upstream activator.  Previous reports have 
identified antagonistic relationship between KLF10 and the functions of EZH2/Polycomb 
Repressive Complex (175).  This data hints to other important chromatin couplings to 
KLF11 that remain to be completely elucidated.  Figure 7B shows the genes affected in 
the presence of the mutant when 486 is inhibited by SREBF1 or JUN and ATF4.  For the 
486 mutant, 6 upstream activators were identified and 15 upstream inhibitors, including 
SREBF2 and HIF1A (Figure 7C).  Although the EAPP did not display any significant 
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upstream regulators as defined by our criteria, a number of other KLF proteins (KLF3, 7, 
13, 1) were significant by p-value, suggesting that inter-association of KLF proteins is 
also critical to their function.  Although a number of the regulators are common to the 
wild type KLF11 and the A347S and 486 mutants, indicating that mutation does not 
necessarily impair upstream regulation or co-regulation, the activation or inhibition of 
these proteins regulates a distinct subset of endpoint genes.  The absence of wild type 
KLF11 targets and acquisition of new, inappropriate targets in the presence of mutation 
places KLF11 chromatin coupling events at the center of the transcription factor’s 
function or dysfunction. 
 
In summary, here we have identified the precise interplay between KLF11 and three of its 
chromatin coupling systems, namely Sin3/HDAC, HP1/HMTs, and WD40 proteins, on a 
genome scale.  The functional repertoire of KLF11 appears to be dictated by both 
combinatorial effects between these systems and singular chromatin coupling events.  
Redundancy, particularly in critical biological processes such as metabolism and 
organismal development, occurs between systems to ensure preservation of critical 
functions.  On the other hand, singular chromatin coupling events exist to ensure 
precision in processes requiring strict spatial and temporal parameters to avoid 
inappropriate signaling. 
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DISCUSSION 
Until recently, the relationship between chromatin and transcription factors appeared 
largely passive. However, the evidence that overexpression of four transcription factors—
Oct4, Sox2, m-Myc, and KLF4—is sufficient to reprogram fully differentiated fibroblasts 
into pluripotent ES-like cells suggests an active role for transcription factors in the 
epigenetic regulation of chromatin state (8).  KLF proteins, in particular, have 
demonstrated a multitude of feed-forward effects on epigenetic regulation of gene 
expression. Here we propose KLF11 as a model for understanding the critical role of 
sequence-specific factors in epigenetic regulation of a multitude of pathobiological 
processes.   
 
KLF proteins deliver epigenetic information to gene promoters through three primary 
mechanisms: (i) sensing and translating environmental stimuli into a program of gene 
expression, (ii) sequence-specific targeting of chromatin remodeling complexes to gene 
promoters, and (iii) transactivation of other transcription factors to assist in the regulation 
of large networks of interdependent genes. Transient regulation of gene expression occurs 
through association with histone acetyltransferases (HATs) and histone 
deacetyltransferases (HDACs), while long-term gene silencing is enacted by interactions 
with histone methyltransferases (HMTs) and DNA methyltransferases (DNMTs).  No 
single classification scheme may accurately characterize the function of KLF11 in its 
entirety. However, the classification of family members by virtue of its co-factors 
provides a framework to understand the functional differences in the manner in which it 
engages chromatin to activate or repress transcription in a dynamic and reversible 
manner.   
 
The association between KLF11 and chromatin coupling is well established.  Initial 
biochemical characterization KLF11 revealed that its N-terminus possesses a domain 
adopts an -helical conformation and that mutations within this domain significantly 
disrupted its binding to  Sin3 and the subsequent recruitment of HDACs (32,34).  
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Subsequently, KLF11 was found to associate with HP1, one of the epigenetic 
“gatekeepers” of gene silencing through its extreme C-terminus (64-66). HP1 proteins 
repress gene expression by binding to H3K9me marks and interacting to H3K9 HMTs, 
such as G9a or SUV39H1, which methylate this residue on adjacent nucleosomes 
(67,68).  Deletion of the C-terminus leads to deregulation of tumor suppression functions 
mediated by KLF11. Finally, KLF11 has also been demonstrated to associate with 
WD40, WWI, WWII, and SH3-domain containing proteins through a proline-rich 
domain.  Interaction of KLF11 and WD40 protein G2, for example, is disrupted in the 
presence of the A347S mutation, the variant associated with development of Maturity 
Onset Diabetes of the Young 7 (MODY7).  The effect of decoupling of KLF11 to 
chromatin co-factors, however, has only been studied on small subsets of genes related to 
the system of focus. 
 
The investigation presented here is the first to attempt to dissect the roles of KLF11 and 
chromatin coupling on a genome-wide level to ascertain the combinatorial or unique 
effects of each type of previously identified interacting chromatin system.  Utilizing a 
single cell type with overexpression of wild type KLF11 and the three previously 
described mutants, A347S, v486, and EAPP, we were able to examine the interplay 
between coupling of the transcription factor to the WD40, HP1/HMT, and Sin3/HDAC 
systems, respectively.  By introducing saturating amounts of each mutant into pancreatic 
epithelial cells, we were able to tease apart the relative and overlapping contributions of 
each chromatin coupling mechanism to the regulation of pathobiological gene networks.  
Our results reveal that in the pancreatic epithelial cell utilized as our model, a large 
number of the affected genes, networks, and signaling cascades are modulated by the 
coupling of KLF11 to its variety of chromatin systems. The number of genes identified as 
regulated independently of these systems represented <1% of the total genes mediated in 
the presence of wild type or mutant proteins. 
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CONCLUSION 
More than fifteen years ago, our research team hypothesized that the discovery and study 
of KLF proteins and their chromatin cofactors would assist in unraveling complex human 
diseases. In the intervening years, our understanding of the interplay between KLF 
proteins and epigenetic machinery in transient and long-term gene regulation has grown 
exponentially. With knowledge inferred from the predictive power of rationally derived 
computational models, we propose a new paradigm for KLF mediation of gene networks 
through the translation of input from cellular milieu into epigenetic information to effect 
changes in chromatin structure.  KLF proteins currently provide the best model for 
understanding the interactions between mechanisms of “hard inheritance” (environmental 
and genetic variation) and “soft inheritance” (epigenetic variation) in underscoring the 
phenotypic variability observed in complex disease mechanisms. Perhaps most 
importantly, these new pathways open up infinite possibilities for targeting new 
molecules and processes in therapeutic intervention and disease management. 
 
MATERIALS AND METHODS 
Cell culture - Panc1 cell lines were obtained from the American Type Culture Collection 
(ATCC, Rockville, MD). Cells were cultured as described previously (118,119).  
 
Constructs - Standard molecular biology techniques were used to clone full length 
KLF11, KLF11-A347S, KLF11-EAPP, and KLF11-486 into pcDNA3.1/His (Invitrogen, 
Carlsbad, CA).  All constructs were verified by sequencing at the Mayo Clinic Molecular 
Biology Core Facility. Epitope-tagged (6XHis-Xpress™) KLF11, KLF11-A347S,  
KLF11-EAPP, KLF11486 variants as well as empty vector (Ad5CMV) were generated 
as recombinant adenovirus in collaboration with the Gene Transfer Vector Core at the 
University of Iowa. 
 
Genome-wide expression profiles of KLF11 and mutants - Panc1 epithelial cells were 
plated at a density of 1x106 cells/100mm dish and transduced with empty vector, KLF11, 
KLF11-A347S, KLF11-486, or KLF11-EAPP at an MOI of 150.  RNA was prepared as 
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previously described from pooled biological triplicates (179). Global gene expression 
profiling was carried out in technical duplicate at the Microarrays Facility of the 
Research Center of Laval University CRCHUL utilizing the Affymetrix Human Gene 1.0 
ST arrays (28,869 well-annotated genes and 764,885 distinct probes). Intensity files were 
generated by Affymetrix GCS 3000 7G and the Gene-Chip Operating Software 
(Affymetrix, Santa Clara, CA).  A subset of genes was validated by qPCR as previously 
described (Supplemental Figure 1) (124,129) 
 
Genome-wide promoter binding profile of KLF11 - Panc1 epithelial cells were 
transfected with full-length His-tagged KLF11.  ChIP was performed as previously 
described (70,116,129,131) using an antibody against the His-Tag (OMNI D8; Santa 
Cruz Biotechnology) to detect recombinant expression of KLF11.  Non-specific IgG 
antibody was utilized as a negative control.  Binding activity was derived using the 
NimbleGen human promoter hybridization system (Madison, WI).  Peaks were detected 
by searching for >4 probes where signals were above the specified cutoff values (90% to 
15%) using a 500bp sliding window along 5kb upstream of the transcriptional start site in 
human promoters.  Each peak was assigned a score that is the log2 ratio of the fourth 
highest probe in each peak.  If multiple peaks are present, the peak nearest the TSS is 
reported.  Ratio data was then randomized 20 times to evaluate the false discovery rate 
(FDR). Only peaks with FDR scores <0.2 were deemed high confidence binding sites and 
reported. 
 
Data analysis - Data analysis, background subtraction and intensity normalization was 
performed using Robust Multiarray Analysis (RMA) (180). Genes that were differentially 
expressed along with false discovery rate (FDR) were estimated from t test (>0.005) and 
corrected using Bayes approach (181,182).   A threshold of +/- 1.5 log2 fold change with 
a p-value with FDR of less than 0.05 (without FDR for EAPP mutant) was used to 
determine significantly regulated targets.  Data analysis, hierarchical clustering, and 
ontology were performed with the OneChanelGUI to extend affylmGUI graphical 
interface capabilities and Partek Genomics Suite, version 6.6 (Partek Inc., St. Louis, MO) 
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with ANOVA and GO ontological analysis (183).  Selected probes and their fold changes 
were loaded into Ingenuity Pathways Analysis Software (Ingenuity® Systems, 
www.ingenuity.com) for annotation, redundancy checks, canonical pathway, biological 
network, and upstream regulator analysis using default parameters.  
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Figure 1: KLF11-mediated gene expression is disrupted in the presence of chromatin coupling 
mutations.  (A) The KLF11 protein is 495 amino acids and contains a highly conserved C2H2 zinc finger 
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domain at its C-terminus.  Known chromatin coupling domains explored in this study are highlighted. (B) 
Panc1 epithelial cells were transfected with wild type KLF11 and chromatin immunoprecipitation 
performed and hybridized to a whole genome promoter array.  404 genes were found bound by KLF11 with 
2000 base pairs upstream and 500 base pairs downstream of transcriptional start sites. Gene ontological 
analysis reveals enrichment of genes in a number of known KLF11-associated biological processes, 
including immune response, TOR signaling, and insulin sensitivity.   For whole genome analysis, mutants 
were designed against three of the previously characterized chromatin coupling domains. The EAPP 
mutation in the N-terminus of the protein decouples the transcription factor from the Sin3/histone 
deacetylase system.  The A347S mutation in the proline rich domain decouples KLF11 from WD40 
containing proteins.  Finally, the deletion mutation starting at amino acid 486 disconnects KLF11 from the 
HP1/histone methyltransferase system.  Panc1 epithelial cells were transduced with empty vector, wild type 
KLF11 or the A347S, 486, or EAPP mutants.  Whole genome transcriptional profiling was performing 
using the Affymetrix Human Gene 1.0 ST array system.  The criteria for significant regulation over empty 
vector was set at a threshold of +/- 1.5 log2 fold change and a p-value with false discovery rate of less than 
0.05.  For the EAPP mutant, the p-value did not include false discovery rate thresholding due to the limited 
experimental effects of this mutant. (C)  75 genes were significantly regulated by overexpression of KLF11 
(p<0.05) that are directly bound by KLF11 as determined by chromatin Immunoprecipitation.  Examination 
of the effects of the overexpression of the three chromatin decoupling mutants reveals that expression is 
frequently altered in the presence of one or more of these variants.   
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Figure 2:  KLF11 differentially couples to distinct chromatin co-factor systems.  (A) Venn diagram of 
the overlap of genes significantly regulated by wild type KLF11 and its mutants.   Genes that occur at the 
overlap of KLF11 and all three of its chromatin-coupling mutants were deemed as independent of the 
effects of chromatin de-coupling and therefore inherent to the protein itself.  (B) Heatmap of the 11 KLF11 
regulated gene that are dependent on interaction with all three chromatin coupling systems. 
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Figure 3:  KLF11 regulates gene expression through combinatorial and singular chromatin coupling 
events.   (A) The A347S mutant, which decouples KLF11 from WD40 proteins, displays the most genome 
wide effects, uniquely affecting the expression of 708 genes, whereas the (B) 486 deletion mutation 
(decouples KLF11 from HP1/histone methyltransferases) and the (C) EAPP mutation (decouples KLF11 
from binding the Sin3 scaffold protein and subsequently histone deacetylases) uniquely regulate only 44 
and 21 genes, respectively.  (D)  Examination of the overlap between genes significantly regulated by the 
A347S mutant reveals that approximately 50% are regulated in a similar fashion to the 486 mutant, 
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although with varying degrees of intensity.  The EAPP mutant, however, displays near complete reversal of 
these targets.  (E)  Wild type KLF11 and the A347S mutant share 411 targets apart from either the EAPP or 
486 mutants, although (F) 352 targets exists that are shared between all three systems.  These data 
indicate that KLF11 chromatin coupling occurs in a largely combinatorial fashion.  (G)  Only 14 genes 
were identified that are uniquely regulated by KLF11, independent of chromatin coupling to the 
transcription factor. Ontological analysis of these genes reveals roles in cancer, cellular proliferation, and 
metabolism. 
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Figure 4: Biological regulated by KLF11 and its chromatin binding partners.  Genes significantly 
regulated by wild type KLF11 and its mutants compared to empty vector were analyzed for enrichment of 
biological processes by an ontological approach.  A threshold off 3 genes and a p-value of less than 0.05 by 
Fisher’s Exact Test were required to be considered significantly regulated by the transcription factor and its 
mutants. (A) Venn diagram of biological processes demonstrates that the A347S mutant causes the largest 
number of genome-wide effects with significant alterations in 150 processes, 93 of which are unique to the 
mutant. Only one biological process, lipid cellular metabolism, is dependent on the combinatorial effects of 
all three chromatin coupling systems.  The top biological processes were computed for each of the proteins 
compared to empty vector.  The pie charts for (B) Wild type KLF11, (C) A347S mutant, (D) 486 mutant, 
and (E) EAPP mutant display the top ten scoring biological processes for each with enrichment percentage 
displayed.  These results indicate that the effects of KLF11 coupling to chromatin co-factors impact on a 
large number of biological functions. 
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Figure 5: Canonical signaling pathways mediated by KLF11 and mutants. Using the Ingenuity Global 
Canonical Pathways algorithm, significantly modulated signaling pathways were identified for wild type 
KLF11 and its mutants.  A p-value of less than 0.05 as determined by Fisher’s Exact Test was used as 
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criteria for significant association of focus genes to predetermined pathways curated from published 
literature.  (A) Venn diagram of significant canonical pathways regulated by wild type KLF11 and mutants 
reveals that the effects of the EAPP mutation are less significant in this experiment compared to the A347S 
and 486 mutants.  These data are supported by the clustering of all significantly regulated targets as shown 
in (B) which demonstrated that the A347S and 486 mutants cluster closely with wild type KLF11 while 
the EAPP mutant clusters with the empty vector control, indicating complete reversal of the effects of the 
other proteins.  (C) Among the 28 top scoring unique canonical pathways mediated by the 374 mutant are 
signaling pathways, including, EGF, PDGR, p53, RANK and reelin signaling, and glucocorticoid receptor 
signaling.  The 486 and EAPP mutants mediate 4 and 6 pathways respectively, both of which are centered 
on processes involved on the degradation of biogenic amines.  These data support KLF11 as a master 
transcriptional regulator that mediates large, interconnected signaling cascades. 
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Figure 6: Biological disease networks mediated by KLF11 and its mutants.  Using Ingenuity’s network 
analysis tool, significantly regulated genes by KLF11 and its mutants were examined for connectivity.  
Networks were scored by relevance and a p-value assigned by Fisher’s Exact Test to discriminate networks 
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generated by chance alone.  A threshold of p<0.05 was employed to determine significant networks. 
Networks were then assessed for association to known biological or disease processes.  Wild type KLF11 
and its mutants share three processes: death and survival, hereditary disorders, and molecular transport.  Of 
the identified processes, 10 are unique to wild type KLF11 and 6 and 8 are unique to the A347S and 486 
mutants, respectively.  A number of known KLF11-mediated biological and diseases processes were 
revealed by this analysis, providing an internal control, including endocrine disorders, gastrointestinal 
disorders, and cellular growth and proliferation processes.  However, the analysis also generated a number 
of novel biological and disease processes that remain to be experimentally validated for KLF11. 
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Figure 7:  Upstream regulators of KLF11 and its mutants.  Gene targets significantly regulated by 
KLF11 and its mutants were analyzed by Ingenuity’s Upstream Regulator Analytic that compares the 
experimentally derive activation or inhibition of focus molecules to relationships between upstream 
regulators and target molecules known from published data.  For each potential upstream regulator and its 
targets, a p-value for the degree of overlap between that of the protein under study and a z-score for the 
activation status are calculated.  For our study, a threshold of p<0.05 and a minimum z-score of +/- 2 were 
employed.  The full results are published in Supplemental Table 5 and sample signaling cascades presented 
for wild type KLF11 (A), A347S (B), and 486 (C).  No cascades were generated that proved significant 
for the EAPP mutant although a more permissive criteria of a p-value of less than 0.05 did generate a 
number of single gene associations listed in Supplemental Table 5, including a variety of other KLF 
proteins, hinting at co-regulation within the KLF family.  Many of the upstream regulators, such as 
PPARG, are previously identified co-regulators of KLF11.  While the upstream regulators frequently 
overlap between wild type and mutant conditions, the end gene targets are unique to each condition.  These 
results suggest that the deregulation of KLF11 from a large number of gene networks is completely 
dependent on the effective coupling of the transcription factor to its chromatin co-factor system.     
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Supplemental Table 1:  Overlapping biological function mediated by KLF11 and mutants. 
 
  
Number of genes Enrichment Score 
GO ID 
Common to KLF11, 
A347S, 486, and 
EAPP KLF11 486 A347S EAPP KLF11 486 A347S EAPP 
44255 
cellular lipid metabolic 
process 15 16 10 2 15.24 9.15 9.61 4.01 
          
  
Number of genes Enrichment Score 
GO ID 
Common to KLF11 
and A347S and 486 
mutants KLF11 486 A347S EAPP KLF11 486 A347S EAPP 
6103 
2-oxoglutarate 
metabolic process 5 4 3 1 9.81 4.89 5.56 3.40 
19432 
triglyceride 
biosynthetic process 6 7 4 1 9.30 7.84 6.09 3.50 
8652 
cellular amino acid 
biosynthetic process 5 5 3 1 6.92 4.29 3.93 3.27 
16139 
glycoside catabolic 
process 2 2 2 1 6.47 5.25 7.07 3.95 
46477 
glycosylceramide 
catabolic process 2 2 2 1 6.47 5.25 7.07 3.73 
43497 
regulation of protein 
heterodimerization 
activity 2 2 2 1 4.91 3.72 5.49 3.50 
35338 
long-chain fatty-acyl-
CoA biosynthetic 
process 3 4 2 1 4.89 5.09 3.30 4.48 
55114 
oxidation-reduction 
process 11 18 9 1 4.55 5.38 4.50 3.31 
43496 
regulation of protein 
homodimerization 
activity 2 2 2 1 4.32 3.16 4.89 3.50 
51607 
defense response to 
virus 4 5 3 1 4.10 3.36 3.31 3.31 
16192 
vesicle-mediated 
transport 9 18 8 1 3.58 6.92 4.24 3.95 
6081 
cellular aldehyde 
metabolic process 2 3 2 1 3.52 4.37 4.08 4.64 
61098 
positive regulation of 
protein tyrosine kinase 
activity 2 3 3 1 3.52 4.37 6.95 3.80 
43627 
response to estrogen 
stimulus 4 8 6 1 3.03 5.60 7.54 3.50 
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Supplemental Table 2: Top biological processes mediated by KLF11 and mutants compared to empty 
vector. 
 
KLF11 EAPP 486 A347S 
cellular lipid metabolic 
process nitric oxide transport 
cellular lipid metabolic 
process 
cellular lipid metabolic 
process 
2-oxoglutarate 
metabolic process 
olfactory bulb 
interneuron 
differentiation 
positive regulation of 
protein binding 
G2/M transition DNA 
damage checkpoint 
triglyceride biosynthetic 
process 
thymine catabolic 
process 
triglyceride biosynthetic 
process 
response to estrogen 
stimulus 
response to insulin 
stimulus 
negative regulation of 
glycolysis proton transport 
glycoside catabolic 
process 
cellular amino acid 
biosynthetic process steroid catabolic process response to hypoxia 
glycosylceramide 
catabolic process 
glycoside catabolic 
process 
ketone body catabolic 
process 
vesicle-mediated 
transport 
positive regulation of 
protein tyrosine kinase 
activity 
glycosylceramide 
catabolic process outer ear morphogenesis 
positive regulation of 
cell growth 
triglyceride biosynthetic 
process 
tricarboxylic acid cycle 
UDP-N-
acetylglucosamine 
biosynthetic process 
cellular nitrogen 
compound metabolic 
process 
response to DNA 
damage stimulus 
glucose metabolic 
process 
cellular ketone body 
metabolic process erythrocyte development 
2-oxoglutarate 
metabolic process 
negative regulation of 
telomere maintenance 
ketone body 
biosynthetic process 
ER to Golgi vesicle-
mediated transport 
regulation of protein 
heterodimerization 
activity 
fatty acid beta-oxidation response to nutrient tricarboxylic acid cycle response to cholesterol 
response to heat response to ethanol 
embryonic digit 
morphogenesis 
response to ionizing 
radiation 
negative regulation of 
IGFR signaling pathway 
glycerol-3-phosphate 
metabolic process 
response to estrogen 
stimulus 
positive regulation of 
protein binding 
cellular response to 
stimulus 
mesenchymal to 
epithelial transition 
polyamine metabolic 
process 
positive regulation of 
DNA repair 
biosynthetic process valine metabolic process 
oxidation-reduction 
process proton transport 
positive regulation of 
cell growth 
regulation of neural 
precursor cell 
proliferation chromatin remodeling 
induction of apoptosis 
by intracellular signals 
cellular nitrogen 
compound metabolic 
process forelimb morphogenesis 
post-embryonic 
development 
regulation of 
transcription, DNA-
dependent 
isocitrate metabolic 
process hindlimb morphogenesis 
glycoside catabolic 
process 
regulation of protein 
homodimerization 
activity 
regulation of protein 
heterodimerization 
activity 
fructose 6-phosphate 
metabolic process 
glycosylceramide 
catabolic process response to folic acid 
L-methionine salvage 
from 
methylthioadenosine oxygen transport 
myeloid leukocyte 
differentiation 
oxidation-reduction 
process 
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Supplemental Table 3: Biological processes unique to the decoupling of KLF11 from WD40 proteins 
(A347S mutant) 
 
List 1 List 2 List 3 
chromatin modification 
chromatin silencing at rDNA 
DNA replication 
DNA-dependent DNA 
replication initiation 
negative regulation of 
centrosome duplication 
nucleotide-excision repair 
positive regulation of DNA 
repair 
telomere maintenance 
telomere maintenance via 
telomere lengthening 
telomere maintenance via 
telomere shortening 
protection from non-
homologous end joining at 
telomere 
protein localization to 
chromosome, telomeric region 
 
negative regulation of protein 
autophosphorylation 
protein dephosphorylation 
histone H3 deacetylation 
methylation 
histone H3-K4 demethylation 
 
transcription elongation from 
RNA polymerase II promoter 
transcription initiation from 
RNA polymerase II promoter 
regulation of transcription 
from RNA polymerase II 
promoter in response to 
oxidative stress 
positive regulation of 
transcription from RNA 
polymerase I promoter 
regulation of transcription 
from RNA polymerase I 
promoter 
termination of RNA 
polymerase I transcription 
mRNA transport 
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Supplemental Table 4: Biological processes unique to the decoupling of KLF11 from HP1a/HMT 
(486 mutant). 
 
List 1 List 2 
beta-amyloid metabolic process 
positive regulation of triglyceride 
biosynthetic process 
L-serine metabolic process 
porphyrin metabolic process 
heme biosynthetic process 
sterol biosynthetic process 
polyamine biosynthetic process 
dopamine biosynthetic process 
folic acid metabolic process 
response to cholesterol 
response to glucose stimulus 
aromatic amino acid family metabolic 
process response to iron ion 
electron transport chain 
regulation of proteasomal protein 
catabolic process 
protein deubiquitination 
protein modification process 
positive regulation of protein export from 
nucleus 
protein import into nucleus, translocation 
positive regulation of protein import into 
nucleus, translocation 
protein autophosphorylation 
vesicle docking involved in exocytosis 
actin cytoskeleton reorganization 
protein tetramerization 
 
positive regulation of epidermal 
growth factor receptor signaling 
pathway 
positive regulation of epithelial to 
mesenchymal transition 
inner cell mass cell proliferation 
positive regulation of epithelial cell 
migration 
cellular response to estradiol stimulus 
negative regulation of survival gene 
product expression 
negative regulation of growth 
induction of apoptosis by intracellular 
signals 
cell death 
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Supplemental Table 5: Upstream regulators of KLF11 and mutants. 
KLF11 URs State Z-score p-value Target molecules in dataset 
PPARG Inhibited -2,323 9,74E-03 
BACE1,BDH1,CPT1A,ERO1L,FASN,GPAM,HY
OU1,IRAK4,IVD,KRT19,PC,PCTP,SLC25A1,SL
C2A1,UCK1 
HNF1A Inhibited -2,000 8,90E-02 
ACAT2,ATG2B,CBS,CCBL2,FBXO8,GATM,GL
A,GOT1,GPR39,KIF20A,KLF11,MON1B,SFXN2
,SUPV3L1 
 
A347S URs State Z-score p-value Target molecules in dataset 
Mechanistic 
Network 
PPARG Inhibited -3,585 2,82E-04 
ACAA1,ACACA,ANGPTL4,ATP6
V1D,BACE1,BCL6,BDH1,CA2,CA
T,CCPG1,CPT1A,ERO1L,F11R,FA
SN,GPAM,HES1,HYOU1,IL12A,IN
SIG1,IRAK4,IVD,JUN,KLF6,KRT1
9,LNPEP,NDUFA5,ODC1,PC,PCTP
,PDHB,PMM1,SAT1,SCD,SDC1,SL
C25A1,SLC25A20,SLC2A1,SORBS
1,SREBF1,TGFBR1,TJP1,TKT,UC
K1,UCP2,VEGFA 
 
RXRA Inhibited -3,386 1,55E-01 
ACACA,ACSL3,ARL4C,CAT,CLM
N,CPT1A,FADS2,FASN,HIF1A,HS
D17B4,ILK,INSIG1,MID1IP1,PC,R
ARG,SAT1,SCD,SDC1,SORBS1,SR
EBF1,TGFB2,VEGFA 
 
STAT4 Inhibited -3,323 1,69E-02 
ACSS1,ADSS,ALDOC,ARFGAP3,
ATF4,ATP7A,EPOR,ERO1L,ERRFI
1,FZD7,GRTP1,HILPDA,HSPA1A/
HSPA1B,ING2,LPIN1,LRRFIP1,M
BOAT2,P4HA2,PRDX6,RNF128,SA
T1,SERPINB1,SETD5,STAT1,VEG
FA 
FOXO4,HIF1
A,TP53 
HIF1A Inhibited -3,257 3,56E-03 
ALDOC,ANGPTL4,BACE1,BNIP3,
BNIP3L,CD24,CHKA,CYB5A,EMC
9,EPAS1,EPOR,ERGIC1,ERO1L,HI
F1A,HILPDA,HIST1H4A (includes 
others),HIST2H2AC,ITPR1,JUN,JU
P,KDM3A,KRT19,LIFR,MCL1,P4H
A1,P4HA2,PFKL,QKI,SDC4,SIRT2,
SLC25A37,SLC29A1,SLC2A1,TAF
9B,TGFB2,VEGFA 
HIF1A,PPAR
G,SREBF1,SR
EBF2,TP53 
PPARGC1A Inhibited -2,930 1,00E00 
ACACA,CALM1 (includes 
others),CAT,CPT1A,FASN,LPIN1,S
CD,SLC25A20,SREBF1,UCP2 
PPARG,SCAP
,SREBF1,SRE
BF2,TP53 
SREBF2 Inhibited -2,875 2,18E-03 
ACACA,ALDOC,CYB5A,DHCR7,F
ADS2,FASN,IDH1,INSIG1,LSS,SC
D,SREBF1,STARD4,TM7SF2 
HIF1A,PPAR
G,SREBF1,SR
EBF2,TP53 
ERG Inhibited -2,828 3,34E-01 
ADD1,ARHGAP17,CDC42BPB,DB
N1,ILK,PIM1,PTPN4,RAB2A,RAS
A2 
FOXO4,HIF1
A,HIF3A,TP5
3 
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ATF4 Inhibited -2,736 1,74E-01 
ATF4,CPOX,DDIT4,ERO1L,JUN,L
GALS3,MCL1,MID1IP1,PYCR1,SL
C7A1,VEGFA 
 
JUN Inhibited -2,660 1,00E00 
ACAT2,CCND2,CYP1B1,DKK1,ER
CC4,EZR,FAS,GTF2B,HES1,HLA-
B,JUN,LGALS3,LMNA,MTHFR,P
ARD6B,PPP2R2A,RARG,SCD,SDC
1,SGK1,SLC6A6,SLC7A1,STAT1,S
TMN1,VEGFA 
 
NFE2L2 Inhibited -2,587 1,00E00 
ABCC4,AKR1A1,ATF4,BNIP3,C5,
CAT,CCRN4L,DCTN3,DHCR7,EP
AS1,EPB41,ESD,IFNGR2,LMNA,N
QO2,SAT1,SEC23A,SLC1A4,SLC2
A1,SREBF1,SYT1,TBRG1,TCN2,U
GDH,USP14,VEGFA 
FOXO4,HIF1
A,PTEN,TP53 
MITF Inhibited -2,540 3,49E-01 
ASAH1,CCNG2,CHKA,GM2A,HIF
1A,ITGA3,IVNS1ABP,LGALS3,PS
EN2,SDC1,SLC19A2,SORT1,TFAP
2A 
ERBB2,FOXO
4,HIF1A,PPA
RG,PTEN,TP5
3,TSC2 
SREBF1 Inhibited -2,530 1,79E-03 
ACACA,ALDOC,CYB5A,DHCR7,
DPY19L3,ELOVL7,FADS2,FAS,FA
SN,GPAM,HSPA1A/HSPA1B,IDH1
,IL12A,INSIG1,LGALS3,LPIN1,LS
S,SCD,SREBF1,STARD4,SUCLG1,
TM7SF2,UCP2,VEGFA 
 
NR1H3 Inhibited -2,453 1,28E-01 
ACACA,ACSL3,ARL4C,FASN,GP
AM,MID1IP1,SCD,SREBF1,VEGF
A 
 
ARNT Inhibited -2,425 1,63E-01 
BNIP3,CCND2,CYP1B1,ERO1L,HI
F1A,KIF20A,MYO1C,SLC2A1,VE
GFA 
 
GLI1 Inhibited -2,268 5,23E-02 
ASPM,CCND2,CD24,CMBL,DKK1
,EZR,IMPA2,INSIG1,JUP,KRT19,L
MNA,MRPS6,NQO2,PIM1,PLOD1,
PPAP2C,RPS6KA1,VEGFA,ZC3HA
V1L 
 
NR1H2 Inhibited -2,236 1,54E-01 
ACACA,FASN,HSD17B4,LRP8,SC
D,SREBF1,VEGFA  
RORA Inhibited -2,236 3,59E-01 
ADIPOR1,ARNTL,CCRN4L,CYP2
C18,ELOVL7,FASN,GSTM2,HSD1
7B7,SCD,SLC16A10,SLC2A13,SRE
BF1,UCP2 
 
MLXIPL Inhibited -2,195 2,52E-02 
ACACA,CPT1A,FASN,MID1IP1,S
CD  
SP1 Inhibited -2,125 1,31E-01 
ACSS1,ALDH3A2,BACE1,BNIP3L,
CAT,CBS,CCND2,CD99,CDC25B,
CYP1B1,EPOR,EZR,FAS,FASN,H
DAC1,HIF1A,HIST1H4A (includes 
others),HSD17B7,HSPA1A/HSPA1
B,IL12A,ITGA2,JUN,KRT19,MAT2
B,MCL1,MSH6,OGG1,PIM1,RBL1,
RECK,SETDB1,SGK1,SLC2A1,SL
C39A8,SLC7A1,SMAD3,SREBF1,S
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TAT1,TGFB2,TGFBR1,UGDH,VE
GFA 
PPARA Inhibited -2,009 2,70E-02 
ACAA1,ACACA,ALDH3A2,ANGP
TL4,C1S,C5,CAT,CHKA,CPT1A,C
YP2C18,DHCR7,F11R,FADS2,FAS
N,GPAM,GPD2,HLA-
E,HSD17B4,INSIG1,KIF20A,LIFR,
LSS,OGG1,PC,PCTP,PPM1D,PRD
X6,QPCT,RAD51B,RETSAT,SAT1,
SCD,SLC25A20,SLC27A2,SOCS2,S
REBF1,TJP1,UCP2,VEGFA 
 
E2f Inhibited -2,000 1,13E-01 
EPAS1,HDAC1,HIF1A,HIST1H3A 
(includes others),HIST1H4A 
(includes 
others),ITGA6,MFAP1,MIR17HG,R
BBP5,RBL1,RECQL,TRMT13 
 
PXR ligand-
PXR-
Retinoic 
acid-RXRÎ± 
Inhibited -2,000 2,87E-01 ALDH3A2,CAT,GSTM2,SCD 
 
PPRC1 Inhibited -2,000 4,40E-01 ATF4,DDIT4,ERRFI1,NAMPT 
 
GFI1 Activated 2,646 3,38E-01 
ATF1,ETS2,JUN,KAT2B,RIPK1,S
MAD3,STAT1,TNFRSF1A  
STAT1 Activated 2,538 1,00E00 
CCND2,FAS,HIF1A,IFI27,IL12A,J
UN,PIM1,SAMHD1,SLFN5,SMAD
2,SMAD3,STAT1,USP18 
 
PIAS1 Activated 2,449 1,40E-02 
ACACA,FASN,MCL1,SCD,SREBF
1,STAT1  
HOXD10 Activated 2,449 3,43E-01 
EZR,HBEGF,ITGA3,NCS1,TJP1,US
P14  
SPDEF Activated 2,449 3,89E-01 
HIF1A,ITGA3,ITGA6,SDC1,SMAD
2,SMAD3  
HIC1 Activated 2,345 2,14E-02 
AHNAK2,CA2,CCDC176,ITPR1,L
RP8,PLEC,SIRT1,SNAPC1,TNS3,
WDR6 
 
EZH2 Activated 2,141 1,00E00 
ANXA6,CCND2,CLDN10,CYB5R2,
CYP1B1,DDT,DKK1,EZR,FUCA1,
SIRT1,TBX3,WTAP 
 
VHL Activated 2,137 1,00E00 
ATF4,BNIP3,CLDN4,EPAS1,HIF1
A,LMNA,SLC2A1,VEGFA  
N-cor Activated 2,000 1,85E-01 
ACACA,FASN,SCD,SREBF1,USP1
8  
 
486 URs State Z-score p-value Target molecules in dataset 
Mechani
stic 
Network 
RXRA Inhibited -3,104 4,65E-02 
ACACA,ARL4C,CAT,CLMN,CPT1A,FA
DS2,FASN,HIF1A,HSD17B4,MID1IP1,S
AT1,SCD,SORBS1,SREBF1,TGFB2 
FOXO3,
FOXO4,
Insulin,P
PARG,S
REBF1,
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SREBF2
,TP53,ar
achidoni
c acid 
PPARGC
1A 
Inhibited -2,774 1,34E-01 
ACACA,CALM1 (includes 
others),CAT,CPT1A,FASN,LPIN1,SCD,S
REBF1,UCP2 
 
PPARG Inhibited -2,652 7,65E-05 
ACACA,BACE1,BCL6,BDH1,CA2,CAT,
CCPG1,CPT1A,ERO1L,FASN,GPAM,H
YOU1,IL12A,IRAK4,IVD,KRT19,LNPE
P,ODC1,PCTP,PDHB,PMM1,SAT1,SCD,
SLC25A1,SLC2A1,SORBS1,SREBF1,TG
FBR1,UCK1,UCP2 
FOXO3,
PPARG,
SREBF1
,SREBF
2,TP53 
NFE2L2 Inhibited -2,578 1,64E-01 
ABCC4,AKR1A1,BNIP3,C5,CAT,DCTN
3,DHCR7,EPB41,ESD,IFNGR2,NQO2,S
AT1,SEC23A,SLC1A4,SLC2A1,SREBF1
,UGDH,USP14 
 
GLI1 Inhibited -2,574 5,22E-01 
CD24,IMPA2,KRT19,NQO2,PIM1,PLOD
1,ZC3HAV1L  
MITF Inhibited -2,414 1,00E00 
GM2A,HIF1A,IVNS1ABP,LGALS3,PSE
N2,SORT1  
ATF4 Inhibited -2,200 1,33E-01 
CPOX,DDIT4,ERO1L,LGALS3,MID1IP1
,PYCR1,SLC7A1  
MLXIPL Inhibited -2,195 1,80E-03 ACACA,CPT1A,FASN,MID1IP1,SCD 
 
TP73 Inhibited -2,138 5,02E-01 
ARNTL,CCNG1,CLMN,DLG1,FASN,ID
H2,SAT1,UBE2D1  
SREBF2 Inhibited -2,128 2,01E-03 
ACACA,CYB5A,DHCR7,FADS2,FASN,
IDH1,LSS,SCD,SREBF1  
NR1H3 Inhibited -2,105 3,55E-02 
ACACA,ARL4C,FASN,GPAM,MID1IP1,
SCD,SREBF1  
HIF1A Inhibited -2,068 3,30E-02 
BACE1,BNIP3,BNIP3L,CD24,CYB5A,E
MC9,ERGIC1,ERO1L,HIF1A,HILPDA,H
IST1H4A (includes 
others),ITPR1,KRT19,LIFR,PFKL,SIRT2,
SLC2A1,TAF9B,TGFB2 
 
NR1H2 Inhibited -2,000 3,00E-02 
ACACA,FASN,HSD17B4,LRP8,SCD,SR
EBF1  
ERG Inhibited -2,000 3,68E-01 ADD1,CDC42BPB,PIM1,PTPN4,RAB2A 
 
RORA Inhibited -2,000 1,00E00 
ARNTL,FASN,SCD,SLC2A13,SREBF1,
UCP2  
HIC1 Activated 2,433 4,37E-02 
CA2,CCDC176,ITPR1,LRP8,TNS3,WDR
6  
HOXA10 Activated 2,236 1,00E00 ATF6B,IDH2,KLF10,SAT1,SCD 
 
STAT1 Activated 2,219 1,00E00 
HIF1A,IFI27,IL12A,PIM1,SAMHD1,SLF
N5,SMAD2  
PIAS1 Activated 2,000 2,22E-02 ACACA,FASN,SCD,SREBF1 
 
N-cor Activated 2,000 7,71E-02 ACACA,FASN,SCD,SREBF1 
 
GFI1 Activated 2,000 2,73E-01 ATF1,ETS2,KAT2B,RIPK1,TNFRSF1A 
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EAPP URs p-value Target molecules in dataset 
ZNF496 1,53E-03 HBB 
FOXN2 1,53E-03 HBB 
HLTF 3,05E-03 HBB 
DLX4 4,57E-03 HBB 
TIAL1 4,57E-03 HBB 
KLF7 6,09E-03 HBB 
ATF4 9,55E-03 DDIT4,STC2 
KLF3 1,06E-02 HBB 
HNRNPD 1,22E-02 HBB 
MAFF 1,37E-02 HBB 
BRCA1 1,48E-02 DDIT4,HBB 
CEBPG 1,52E-02 HBB 
CBX2 1,67E-02 HBB 
MTA2 1,67E-02 HBB 
KLF13 1,82E-02 HBB 
NSD1 1,97E-02 HBB 
CTBP2 2,27E-02 HBB 
ZFPM1 2,27E-02 HBB 
GLI1 2,32E-02 GREM2,SALL1 
COMMD3-BMI1 2,57E-02 HBB 
MAFK 2,57E-02 HBB 
SIX1 2,71E-02 SALL1 
NFE2 2,71E-02 HBB 
BACH1 2,71E-02 HBB 
CARM1 3,16E-02 STC2 
DRAP1 3,60E-02 HIST1H2BH/HIST1H2BO 
KLF1 4,04E-02 HBB 
GTF2B 4,04E-02 HIST1H2BH/HIST1H2BO 
YBX1 4,19E-02 HBB 
KAT2B 4,34E-02 HBB 
HOXC8 4,34E-02 GREM2 
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CONCLUSION 
 
These studies on KLF in the delivery of epigenetic information reveal a novel role for the 
nucleosome as a cellular nanomachine that translates KLF inputs into epigenetic outputs 
to regulate networks of related gene targets. We hypothesize that these mechanisms have 
evolved in eukaryotes as a means for translating environmental stimuli into the regulation 
of gene networks, thereby serving as the basis for the epigenetics of environment-gene 
interactions. While much of the evidence for this paradigm emerges from the field of 
metabolism, it is tempting to speculate—given the diverse range of KLF functions—that 
these principles also apply to the regulation of gene networks in general (e.g. cell cycle, 
differentiation). 
 
In this paradigm (Figure 1), environmental signals are channeled from the membrane to 
the nucleus through signaling transduction cascades that impinge upon KLF transcription 
factors, activating or repressing their activity through posttranslational modification. 
Activated KLF proteins function as master transcription factors at the apex of a cascade 
of gene promoters (nodes) that form an interrelated gene network affecting a specific 
function (e.g. glucose metabolism, differentiation). The character of the KLF factor, the 
context of the promoter sequence, and the interaction with co-repressors or co-activators 
determine the type of epigenetic information delivered to a gene promoter by a particular 
factor. Antagonism between HATs and HDACs serves as a switch for the transient 
epigenetic status of the promoter, permitting rapid activation or repression of a gene 
target, respectively. In repressed targets, KLF/HDACs may recruit long-term silencing 
machinery, HMTs and DNMTs, to make the repressed status of a gene permanent. 
Among the targets transactivated by KLF proteins are additional transcriptional factors 
(regulation nodes). Increases or decreases in the intracellular concentration of these 
transcription factors act as a feedback to modulate the output of the pathway.  
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KLF conducts a veritable symphony of gene expression through diverse gene orchestras 
to underscore the entire gamut of biological functions. The old paradigm of 
transcriptional factors turning genes “on” or “off” by simply binding to a single site 
consensus sequence is woefully outdated.  Transcription is regulated through intricate 
interactions between the transcription factor, its promoter, and its associated co-factors 
interacting in close proximity to fine-tune the intensity of activating or repressive signals 
from the environment or within the cellular milieu. 
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FIGURE 1. KLF are conductors of diverse gene orchestras.  KLF is the central mediator in a diverse 
range of biological functions, from development to metabolism.  Environmental stimuli from the external 
environment are transduced through intercellular signaling cascades leading to the sequence-specific 
recruitment of KLF molecules to gene promoters, which, thanks to their coupling with a variety of 
epigenetic molecules that determine their activating or repressing quality, are responsible for remodeling 
chromatin and turning genes “on” and “off.”  As other transcription factors are frequently the targets of 
KLF-mediated activation or repression, the molecule is poised to regulate large gene signaling cascades. 
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